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ABSTRACT 
 
Harpagophytum procumbens is a traditional medicinal plant widely used in South African 
traditional healthcare to treat a range of ailments like degenerative rheumatoid arthritis, 
osteoarthritis, tendonitis, kidney inflammation, heart disease, dyspepsia and loss of appetite. 
Analgesic and anti-inflammatory effects of Harpagophytum procumbens has been reported to 
decrease due to stomach acidity. In addition, dried plant extract is water soluble and has poor 
lipid solubility severely limiting its ability to pass across lipid-rich biological membranes. To 
overcome this, plant extract was incorporated into a nano lipid alginate coated bead.  
Harpagophytum procumbens freeze dried aqueous extract was prepared and the active 
principle harpagoside was identified by mass spectrometry (MS). A simple, linear, accurate 
and precise UHPLC method was developed for quantitative determination of the bioactive 
harpagoside.  Harpagophytum procumbens was encapsulated in lipid vesicles (liposomes and 
phytosomes) by using a dry film hydration technique and characterized for particle size, 
polydispersity index and encapsulation efficiency.  
Statistical response surface methodology (RSM) experimental design was used for lipid 
vesicles formulation optimization. The effects of formulation parameters (input factors) 
phosphatidylcholine ratio, cholesterol ratio and type of the lipid vesicle on output factors 
particle size, polydispersity index and percentage entrapment efficiency was investigated. 
Experimental design was statistically validated by ANOVA and suitable model for each 
output factor was selected based on non-significant lack of fit p-value and R
2
 values.  The 
design matrix showed that particle size of lipid vesicles enhanced as phosphatidylcholine and 
cholesterol content increases. The particle size of lipid vesicles was in a range of 382.6 to 
608.7 nm for liposomes for phytosome was in a range of 207.8 to 596.4 nm. The design 
matrix also showed that polydispersity index decreases as phosphatidylcholine and 
cholesterol concentration increases which reflects complete complexion. Phosphatidylcholine 
had a more positive effect on encapsulation efficacy than cholesterol. High cholesterol 
content generally decreased percentage encapsulation. 
Once the desirability function was included for formulation optimization, the optimized 
formulation was phosphatidylcholine 80 %, cholesterol 5 % and type of lipid vesicle was 
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phytosomes. The predicted values of these vesicles was, particle size 531.29 nm, poly 
disparity index  0.23 and percentage encapsulation efficiency 31 %  and a  desirability of 
0.77. The optimized formulation was verified in 4 replicates and the results were similar to 
the predicted results. 
The zeta potential of the optimized formulation was outside the recommended range. Hence, 
stearic acid was added to the optimized H. procumbens phytosomes formulation as a surface 
charge inducer. The zeta potential was significantly (p ˂ 0.05) improved when stearic acid 
was added to the optimized formulation from −8.3 ± 0.72 to –30.6 ± 0.80 mV. 
Scanning electron microscopy confirmed the formation of the phospholipid vesicles upon 
hydration of thin lipid film. FTIR analysis indicated the interaction of plant extract to the 
polar end of the phosphatidylcholine through formation of strong hydrogen bonding between 
the hydroxyl group of phospholipid and extract phytoconstituents. 
The phytosomes showed instability in simulated gastric SGF (pH 1.2), demonstrated by 
increase in the particle size, polydispersity index and a reduction in zeta potential after 4 
hours of  incubation. 
H. procumbens phytosomes was encapsulated in alginate beads in order to protect 
phytosomes integrity. This was performed to overcome degradation of the plant extract in an 
acidic environment. Alginate coated H. procumbens phytosomes were successfully prepared 
by inotropic gelation technique by using sodium alginate and calcium chloride as a cross-
linking agent. Alginate coated H. procumbens phytosomes formulations at 2 % sodium 
alginate and 4% calcium chloride was found to be the best parameter values.  
The alginate-coated H. procumbens phytosomes exhibited high swelling rate in simulated 
intestinal fluid (SIF) pH 7.4 (92 %), while the swelling rate was lower in gastric simulated 
fluid (SGF) pH 1.2 (19 %), this is a desirable result. The alginate-coated H. procumbens 
phytosomes in acidic media (SGF) showed no release over the 4 hours and no signs of bead 
disruption. 
 The in vitro release study showed that phytosomes and alginate-coated H. procumbens 
phytosomes entered a slow-release phase and delayed the harpagoside release, compared to 
conventional freeze dried plant extract. H. procumbens phytosomes demonstrated Fickian 
diffusion release mechanism of harpagoside and its release from alginate-coated H. 
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procumbens phytosomes was predominantly by both diffusion drug release and anomalous 
transport (swelling controlled drug release). 
At lower temperature conditions, i.e. 4-8 °C, the phytosomes showed fairly high retention of 
active in the vesicles over 30 days with only 8.82 % leak.  As for alginate coated H. 
procumbens phytosomes, alginate beads exhibited satisfactory stability under all exposed 
temperatures; however, they showed negligible leaking at the end of 30 days at 37 °C.  
Overall, water soluble phytoconstituents of freeze dried H. procumbens extract can be 
converted to alginate coated phytosomes complexes. This can be considered a promising 
vehicle for control delivery of H. procumbens extract as it minimizes release in simulated 
gastric environment and breakdown in simulated intestinal environment which could lead to 
increased availability of phytosomes for small intestine absorption.
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Chapter 1                         
Introduction 
 
1.1 Background and Problem Definition 
Medicinal plants are commonly used in South African traditional healthcare to treat a range 
of ailments (Clarkson et al., 2004). According to recent estimates by the World Health 
Organisation (WHO), more than 3.5 billion people in the developing world rely on plants as 
components of their primary health care (Xego et al., 2016).   
South Africa is a country with a strong history of traditional healing which hosts around 
30,000 plant species of which 3000 species are used therapeutically. Around 80% of the 
South African population use traditional medicines for their primary health care needs 
(Street, 2012). The reliance on traditional medicine of such a large portion of the population 
can be attributed to a number of factors; relatively good accessibility to the plants, 
affordability and extensive local knowledge and expertise amongst the communities (Street et 
al., 2008).   
One of the phytopharmaceuticals that exert anti-inflammatory effects is Harpagophytum 
procumbens (Pedaliaceae). Extracts of this herbal drug have become the focus of research as 
a potential therapeutic agent in the treatment of arthritis and pain due to its favourable side 
effects profile compared to synthetic alternatives. Moreover, non-steroidal anti-inflammatory 
drugs (NSAIDs) are often associated with serious adverse effects in long-term use, such as 
gastric ulceration, hepatic toxicity, and haemorrhage (Tan et al., 2016).  
Harpagophytum procumbens, also known as Devil‘s Claw, is an herbaceous plant species 
that has high medicinal value in southern Africa (Lim et al., 2014). This plant grows mainly 
in Namibia, Botswana, Zimbabwe and South Africa. The secondary tubers of H. procumbens 
are effective in the treatment of degenerative rheumatoid arthritis, osteoarthritis, tendonitis, 
kidney inflammation (Mncwangi et al., 2012). Therefore, H. procumbens has been 
increasingly considered an alternative to non-steroidal anti-inflammatory drugs (Ludwig-
Müller et al., 2008.). Harpagoside is   believed to be a main bioactive compound of H. 
procumbens related to the anti-inflammatory efficacy of this plant (Kim et al., 2015).  
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H. procumbens has been claimed to possess inhibition potential of inducible nitric oxide 
(NO), inflammatory cytokines (IL-6, IL-1𝛽) and  tumour necrosis factor-alpha (TNF-𝛼), and 
prostaglandine-2 (PGE2), direct inhibition of cyclooxygenase-2 (COX-2) enzyme as well as 
prevention of arachidonic acid metabolism and eicosanoid biosynthesis, leading to COX-2 
inhibition and reducing inflammation (Gyurkovska et al., 2011; Akhtar et al., 2012; Ebrahim 
et al., 2011; Sheu et al., 2015).  
H. procumbens was mainly administered as one of the following: an infusion, decoction, 
tincture, powder, and extract. While infusions and decoctions are the most central traditional 
methods of preparation, the main active principles in the plant are prone to hydrolysis (Street 
et al., 2012). It has been proposed that stomach digestion influences the pharmacological 
activity of H. procumbens (Hostanska et al., 2014; Soulimani et al., 1994) resulting in 
reduced activity when administered orally (Catelan et al., 2006). This may be due to acid 
hydrolysis or denaturing of the active principles as they pass through the stomach (Soulimani 
et al., 1994; Mncwangi et al., 2012).  
Encapsulation of plant extract in lipid based drug delivery systems might be a good solution 
for protecting the plant material and obtaining the required properties. The bioavailability and 
absorption of water soluble phytoconstituents is erratic due either to their large molecular size 
which cannot be absorbed by passive diffusion, or to their poor lipid solubility in the 
gastrointestinal tract. This severely limits their ability to cross the lipid-rich biological 
membranes, resulting in poor bioavailability (Bhattacharya et al., 2009; Udapurkar et al., 
2016). This could be overcome by a novel drug delivery system (NDDS); that converts the 
water‐soluble plant extract molecules into a lipid‐compatible molecular complex.  
Nanotechnology may be applied to NDDS that enables a weight reduction of drug particles 
accompanied by an increase in stability and improved functionality. Various approaches such 
as liposomes, niosomes, and phytosomes, are used for the enhancement of bioavailability 
(Abhinav et al., 2016). These systems have various advantages over the traditional 
formulations such as improved solubility & bioavailability, controlled drug delivery, 
protection of plant actives from degradation (Sharma et al., 2016).  
Liposomes and phytosomes are microscopic vesicles consisting of phospholipid bilayers and 
are utilized for hydrophilic and lipophilic drugs (Udapurkar et al., 2016). The basic difference 
between liposomes and phytosomes is that, in the former, the active biomaterial is dissolved 
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in the internal pocket or it floats in the layer membrane, whereas in phytosomes the active is 
anchored through chemical bonds to the polar phospholipids heads and becomes an integral 
part of the membrane, while no bonds are formed in liposomes (Rawat et al., 2012). 
Phytosomal technology has been effectively used to enhance the bioavailability, solubility, 
prolong the duration of action, reduce side effects and increase therapeutic effect of many 
popular plant extracts. Some of the phytoconstituents incorporated in phytosomes include 
extracts of Ginkgo biloba, grape seed, milk thistle (Sharma, 2014, Saraf, 2010) and in 
liposomes include colchicine, silymarin, and rosemary essential oil (Mathur, 2013,  Kiaee  et 
al., 2016).  
Following oral administration, the lipid component of the lipid based drug delivery system 
(liposomes and phytosomes) may be subjected to hydrolysis in the presence of acidic pH and 
eliminate the encapsulated plant materials and lose their function as a carrier. Hence, to 
overcome this, a possible solution is to coat the lipid vesicles with pH sensitive polymer 
matrices. This serves to protect the lipid vesicles from the influence of acidic environment 
and promote their breakdown in the intestinal medium for increased absorption of the intact 
liposome or phytosomes.  
Alginate is a polysaccharide found in brown algae, composed mainly by linear polymers of β-
(1-4)-D-mannuronic (M) and α-L-gluronic (G) acids, which are different in terms of their 
proportions and linear arrangements (Xu et al., 2017). Alginate, a pH sensitive polymer 
stable at acidic pH but unstable in alkaline medium (intestinal environment) (Abbas et al., 
2017), have been proven to protect compounds from hostile environments, such as low pH 
and enzymes in the stomach. It enhances the stability of drug delivery in the stomach and 
achieves controlled release in the intestine (Liu et al., 2017). Sodium alginate is a suitable 
carrier matrix because it is biodegradable, biocompatible and nontoxic orally (Devi et al., 
2010) and has been used as a gastro-resistant carrier in simulated gastric fluid (Smith et al., 
2010; Cerciello et al., 2016). 
  
Inspired by this knowledge we aimed to design a novel delivery system based on alginate 
hydrogel micro beads containing Harpagophytum procumbens extract loaded lipid vesicles 
(liposomes) to enhance the stability in the acidic region of the gastro-intestinal tract for 
improved intact delivery and release of liposomes in the small intestinal environment. 
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1.2 Aim and objectives of the study 
The aim of the study is to develop an optimized lipo/phytosomal carrier system consisting of 
Harpagophytum procumbens coated with alginate for protection from gastric digestion.  To 
achieve the aim the following objectives were set: 
 
 Development and validation of a rapid, simple and reliable UHPLC method for 
identification and quantification of harpagoside in Harpagophytum procumbens crude 
plant extract. 
 Preparation of liposomes and phytosomes formulations containing Harpagophytum 
procumbens plant extract.  
 Optimization studies of liposomes and phytosomes formulation parameters using 
response surface methodology (RSM). 
 Physio-chemical characterization of prepared liposomes and phytosomes.  
 Formulation and development of an alginate coating method for phytosomal 
formulation encapsulation. 
 To perform in vitro stability of the optimized nano lipid vesicles and alginate coated 
beads in simulated gastric and intestinal medium.  
 Determine the mechanism of release of harpagoside from phytosomes and alginate 
coated phytosomes. 
 Determine the stability of harpagoside in phytosomes and alginate coated phytosomes 
at various temperatures over time. 
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Chapter 2                                   
              
Literature review 
 
2.1 Background 
For a very long time, herbal medicine has a topic of global importance, making an impact on 
both world health and international trade. Medicinal plants continue to play a central role in 
the healthcare system of large proportions of the world‘s population (Akerele, 1988). This is 
particularly true in developing countries, where herbal medicine has a long and uninterrupted 
history of use. Recognition and development of the medicinal and economic benefits of these 
plants are on the increase in both developing and industrialized nations (WHO, 1998).  
The WHO estimates that up to 80 percent of people still rely on herbal remedies for their 
health care (Mahomoodally, 2013). Several factors are responsible for this, namely, the high 
cost of drugs, drug resistance which often lead to treatment failure and expensive treatment of 
some chronic diseases which the general populace cannot afford (Afolayan et al., 2004). In 
Africa, traditional healers and remedies made from plants play an important role in the health 
of millions of people. There are an estimated 200 000 indigenous traditional healers in South 
Africa and up to 80 % of South Africans consult these healers, usually in addition to using 
modern biomedical services (Xego et al., 2016). It is estimated that over 3000 species of 
South African plants are used regularly in traditional medicine and around 38 species are 
being exploited commercially which include Harpagophytum procumbens ‎ (Kuete, 2013). 
 
2.2 Harpagophytum procumbens ‎ 
2.2.1 Description 
Harpagophytum procumbens (H.procumbens) is a perennial herb belonging to the 
pedaliaceae family commonly known as Devil‘s Claw. Other common names include grapple 
plant, wood spider, and harpago. The vernacular name, Devil‘s Claw is derived from the fact 
that the fruits of the plant are covered in small claw-like protrusions. Similarly, its herbal 
name Harpagophytum translates from the Greek ‗harpago‘, which means ‗a grappling hook‘ 
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(Grant et al., 2007). A photograph of H. procumbens ‎ leaves; flower and fruit can be seen in 
figure 2.1. 
 
 
Figure 2-1: H. procumbens ‎ with flower, fruit (seed capsule) and bluish green                  
leaves. (Source: Muzila, 2016). 
 
The part used medicinally is the water-storing secondary tuberous roots as can be seen in 
figure 2.2 which are formed in order to survive the dry seasons encountered in the sub-
Saharan regions. The roots are harvested and subsequently sliced into sections and dried 
before being used therapeutically (Grant et al., 2007). 
 
 
Figure 2-2: H. procumbens  ‎with secondary tubers. (Source: Georgiev et al., 2013.). 
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H. procumbens ‎ plant tubers have been used by the native population of southern Africa for 
treating a number of ailments, including fever, diabetes, diarrhoea and blood diseases (Van 
Wyk et al., 2011). More recently, extracts of the secondary roots of the species have been 
found to be effective in the treatment of degenerative rheumatoid arthritis, osteoarthritis, 
tendonitis, kidney inflammation and heart disease (Georgiev et al., 2010). Therefore H. 
procumbens  has been increasingly considered an alternative to non-steroidal anti-
inflammatory drugs (Georgiev et al., 2010). 
 
2.2.2 Geographical distribution and habitat 
H. procumbens ‎ occurs in Namibia, Botswana, South Africa, Angola and to a lesser extent 
Zambia, Zimbabwe and Mozambique, the geographical distribution of H. procumbens ‎ is 
depicted in figure 2.3. It typically grows in areas with low annual rainfall such as the red 
sandy soils of the Kalahari desert. Both the abundance and visibility of the plant strongly 
depends on rainfall. It is most abundant in open, overgrazed areas as it does not compete well 
with grasses and has a clumped distribution (Stewart et al., 2005). To enable survival during 
long severe dry periods, the plant forms water-storing secondary tubers which branches off 
horizontally from the primary tubers.  
 
 
Figure 2-3: Geographical distribution of H. procumbens (region 1). (Sorec: Mncwangi et al., 
2014). 
 
2.2.3 Phytochemistry: Main and active constituents 
H. procumbens has been known as a medicinal plant with the San of the Kalahari having  
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used it first, many generations ago. The major chemical constituents of Harpagophytum are 
iridoid glycosides (primarily harpagoside, harpagide, and procumbide), sugars (mainly the 
tetrasaccharide, stachyose), triterpenoids (oleanolic and ursolic acid), phytosterols (primarily 
beta-sitosterol), aromatic acids (caffeic, cinnamic, and chlorogenic acids), and flavonoids 
such as luteolin and kaempferol (Akhtar et al., 2012). However, the main pharmacological 
activity of H. procumbens extracts is attributed to harpagoside, and its content is used to 
standardize commercial H. procumbens products, which should contain at least 1.2 % of the 
compound. Iridoid glycosides are believed to act synergistically or antagonistically in 
modulating the enzymes responsible for inflammation. However, most official monograph 
specifications are based on harpagoside content alone (Viljoen et al., 2012).  
 
2.2.4 Clinical usefulness 
The European Scientific Cooperative on Phytotherapy (ESCOP) monograph ESCOP 
recommends the use of Devil's claw for symptomatic treatment of painful osteoarthritis, relief 
of low back pain, loss of appetite, and dyspepsia (Babili et al., 2012). It has also been used as 
a folk remedy for the relief of arthritis, lumbago, and muscular pain and has anti-rheumatic 
and anti-inflammatory properties (Naidoo et al., 2014). It has been shown to exhibit a variety 
of biological activities and used as pharmaceutical products for the treatment of inflammatory 
ailments, rheumatoid arthritis, and osteoarthritis (Chrubasik et al., 2007). Several clinical and 
animal studies have demonstrated the efficacy of H. procumbens  in rheumatic diseases, in 
addition to its analgesic properties (Andersen et al., 2004). Several investigations have also 
found that extracts have good anti-inflammatory and analgesic activities in carrageenan-
induced acute inflammation (Dimitrova et al., 2013). 
A standardized extract of H. procumhens has been shown to alleviate rheumatic pain 
(Chrubasik et al., 2000). Preparations are also used in the treatment of osteoarthritis (OA) 
(Saanders et al., 2011; Chrubasik et al., 2007). A recent study by Gyourkovska, et al. (2011) 
reported anti-inflammatory action by several fractions as well as pure compounds of this 
extract. 
 
2.2.5 Pharmacological effect as anti-inflammatory  
H. procumbens has anti-inflammatory effects (Viljoen et al., 2012) through a variety of 
mechanisms for inflammation. The main mechanism is by inhibiting the release of different 
pro-inflammatory mediators. A review of clinical trials utilizing its preparations for the 
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treatment of inflammatory disorders shows that extracts from tubers of H. procumbens also 
inhibit different pro-inflammatory mediators; suppressed the release of TNF-α (tumor 
necrosis factor gene), IL-6 and IL-8 (interleukins genes expression), in LPS-stimulated 
monocytic THP-1 cells at non-cytotoxic concentrations, thereby inhibiting inflammation (50-
250 μg/ml) (Hostanska et al., 2014). Extracts tested on isolated murine macrophages, has 
shown strong anti-inflammatory properties related to nitric oxide (NO) and cytokine (TNF-a 
and IL-6) release as well as COX-1 and COX-2 inhibition expression by macrophages 
(Gyurkovska et al., 2011). Ebrahim and Eubel, (2011) demonstrated direct inhibition of 
COX-2 enzyme by H. procumbens extract and its active components namely, harpagoside 
and harpagide. 
 
2.2.6 Dosage forms 
H. procumbens was first administered as an infusion but currently it is almost exclusively 
supplied as an ethanol tincture or as a dry extract in tablet or capsule form (Grant et al., 
2007). However, the dried extract is generally more acceptable than the solution form, but it 
may also have further disadvantages. For instance, the dried extract powder may not have 
uniform particle size, adequate flow characteristics and might be hygroscopic. Further, it has 
been proposed that stomach digestion influences the pharmacological activity of H. 
procumbens. Some studies have indicated that the analgesic and anti-inflammatory effects of 
H. procumbens are decreased by the acidity of stomach due to acid hydrolysis or denaturing 
of the active principles (Bone et al., 2013; Soulimani et al., 1994).  Catelan et al. reported 
that the intraperitoneal administration of H. procumbens extracts administered to rats 30 min 
prior to carrageenan injection exerted inhibitory effects on the acute inflammatory response. 
More importantly, they observed it was ineffective to reduce the intensity of inflammatory 
response when administered orally (Catelan et al., 2006).  
The delivery of plant/herbal therapeutic molecules is problematic due to poor solubility, poor 
permeability, low bioavailability, instability in biological milieu and extensive first pass 
metabolism. These limitations of herbal drugs can be overcome by attaching or encapsulating 
them with suitable nanomaterials. The nanomaterials can significantly enhance the 
pharmacokinetics and therapeutic index of plant drugs. Targeted delivery and combination 
therapy can drastically improve the performance of herbal drugs (Kumari et al., 2012). 
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2.3 Intestinal absorption 
The most desirable route of administration for therapeutic agents is oral; as it avoids pain and 
risk of infection associated with parenteral administration and thereby increases patient 
compliance. However most of the orally administered drugs display low systemic availability 
and diminished efficacy (Gavhane et al., 2012). As for the drug absorption after oral 
administration, the gastrointestinal (GI) transit of a drug is an important factor to determine 
the drug absorption (Kimura et al., 2002). The luminal environment is complex, and drug 
absorption may be affected by several physiological factors, including volume and viscosity 
of the gastrointestinal fluids, the pH and buffer capacity of these fluids. These can vary 
greatly in different regions of the gastrointestinal (GI) tract (Fadda et al., 2010). One 
requirement for successfully delivering drugs orally is by protecting drugs from degradation 
in the acidic environment (low pH) of stomach. Figure 2.4 shows the pH range in the GI tract. 
 
 
Figure 2-4: Varying pH in the gastrointestinal tract (source, Khutoryanskiy et al., 2015). 
 
The stomach is typically the first section of the GI tract, in which disintegration and 
dissolution take place. The intestines are the main absorption site for nutrients and drugs. 
Moreover, literature suggests a subsequent increase of the pH value from pH 6 in the 
duodenum to pH 7–8 in the terminal ileum. The transit time through the small bowel in 
healthy humans typically amounts to 3 to 6 hours (Koziolek et al., 2015).  
The investigation of drug dissolution in media mimicking gastric and intestinal conditions is 
required to understand drug formulations and their delivery processes. Dissolution testing is 
frequently used to determine the rate and extent at which a drug released from a dosage form 
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and it plays many important roles throughout drug product development (Fang et al., 2010). 
Drug dissolution in the physiological environment of the GI tract is the primary step in the 
oral absorption process from a pharmaceutical dosage form. 
During drug dosage form development it is essential to investigate factors which influence 
absorption especially after oral administration (Dressman et al., 2000). Simulation of 
gastrointestinal conditions is essential to adequately predict the in vivo performance of drug 
formulations. In vitro dissolution tests should mimic a drug performance in a human proximal 
gastrointestinal tract (GIT). To establish reliable in vitro testing it is important that artificial 
environments simulate physiological conditions as closely as possible. The level of the 
simulation is dependent on many factors related to equipment and simulated medium 
(Gruberova et al., 2017).  
 
2.3.1 Simulated Gastric Fluid (SGF) 
SGF is a traditional medium to simulate gastric conditions. This synthetic fluid will mimic 
the effect of the gastric juice in the stomach on a particular drug. This medium contains 
hydrochloric acid and sodium chloride and water, and has a pH of 1.2. Drugs made for 
dissolution and disintegration in the small intestine must not disintegrate or dissolve in the in 
the Simulated Gastric Fluid (SGF). On the other hand, drugs designed to act in the stomach 
will dissolve in this synthetic solution of Simulated Gastric Fluid (SGF) (Klein, 2010).  
 
2.3.2 Simulated Intestinal Fluid (SIF) 
SIF is an artificial dissolution medium form of intestinal solution for the simulation of small 
intestinal (SI) conditions. It is used to predict the in vivo behaviour of drug formulations 
when administered orally (Klein, 2010). The extent to which the analysed pharmaceutical 
dissolves and releases it actives in the simulated intestinal is a good indicator of how the 
pharmaceutical will be available for absorption into the system from the villi in the intestine.  
Simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) are widely used media in 
dissolution tests in the pharmaceutical industry to mimic the natural environment in which 
the dosage forms will be administered and to evaluate the predictive capability of a 
dissolution test.  More commonly SGF and SIF media are prepared and utilized in dissolution 
tests without enzymes (Medina et al., 2017). 
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2.4 Nanotechnology 
Nanotechnology is defined as the intentional design, characterization, production and 
application of materials, structures, devices, and systems by controlling their size and shape 
in the nanoscale range (Solano-Umaña et al., 2015). Nanotechnology plays a central role in 
the recent technological advances in the areas of disease diagnosis, drug design and drug 
delivery and could overcome challenges such as drug toxicity, sustaining the release of drugs 
in the body and improving bioavailability. Drugs, which are water insoluble and unstable in 
the biological environment, may be delivered properly with nanotechnology. Nanostructures 
can protect drugs from hydrolytic and enzymatic degradation (Caban et al., 2014). They also 
prevent drugs from first-pass metabolism and increase the blood residence time. They can 
penetrate tissues efficiently due to their reduced size. In addition, drugs which are produced 
at nanoscale may pass biological barriers (Caban et al., 2014). Nanostructures exhibit unique 
physicochemical and biological properties (e.g., an enhanced reactive area as well as an 
ability to cross cell and tissue barriers) due to their small sizes, which make them a 
favourable material for biomedical applications (Abhinav et al., 2016). Various approaches 
such as liposomes, niosomes, nanoemulsions, phytosome etc., are used for the enhancement 
of bioavailability (Abhinav et al., 2016). 
 
2.5 Lipid-based drug delivery systems 
Lipid based drug delivery systems (LDDS) consists of a diverse group of formulations, each 
consisting of varying functional and structural properties that are amenable to modifications 
achieved by varying the composition of lipid excipients and other additives. Generally, most 
lipid drug delivery systems used as drug carriers have high stability, high carrier capacity, 
feasible for incorporating into both hydrophilic and hydrophobic substances and variable 
routes of administration, including oral, topical, parenteral and pulmonary routes (Chime et 
al., 2013).  
Lipids have gained much interest as carriers for the delivery of drugs with poor water 
solubility (Pouton, 2006). The availability of novel lipid excipients with acceptable 
regulatory and safety profiles coupled with their ability to enhance oral bioavailability has 
helped in the development of lipid based formulations as a means for drug delivery 
Lipid-based formulations, in many cases may reduce or eliminate the influence of food on the 
absorption of these drugs (Shrestha et al., 2014). Despite this, marketed oral drug products 
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employing lipid-based formulations are currently outnumbered 25 to 1 by conventional 
formulations (Shrestha et al., 2014).  
Lipid-based formulations can be applied to influence the absorption of active ingredients 
through different mechanisms, such as modifying the release of active ingredients, improving 
their bioavailability and stability, changing the composition and character of the intestinal 
environment, stimulating the lymphatic transport of active ingredients, and interact with 
enterocyte-based transport processes and reducing unwanted drug side effects (Fricker et al., 
2010). 
 
2.5.1 Types of lipid based systems  
A wide variety of lipid based systems have been explored and it is broadly classified into 
three types, namely, emulsion based system, vascular system and lipid particulate system. 
These systems have the potential to solubilize the drug in a controlled manner with a unique 
mechanism for each classification of lipid based drug delivery systems are given in figure 
2.5. 
 
 
Figure 2-5: Classification of lipid based drug delivery system. (Source: Singh, 2015).  
 
2.5.2 Liposomes  
The word ―liposome‖ is derived from two Greek words viz. lipo- meaning fat and soma-
meaning body. They were called ―Bangasomes‖ honouring Dr. Bangham, and finally 
liposomes (Kim, 2016). A liposome is colloidal, spherical vesicle with a membrane 
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composed of a phospholipid bilayer used to deliver drug or genetic material into a cell. 
Liposomes were first produced in England in 1961 by Alec D. Bangham, who found that 
phospholipids combined with water immediately and formed a sphere because one end of 
each molecule is hydrophilic, while the opposite end is hydrophobic. Water soluble 
medications added to the water were trapped inside the aggregation of hydrophobic ends 
while fat-soluble medications were incorporated into the phospholipid layer (Shailesh et al., 
2009). 
Liposomes are the most common and well-investigated nanocarriers for targeted drug 
delivery. They have improved therapies for a range of biomedical applications by stabilizing 
therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving 
biodistribution of compounds to target sites in vivo (Ding et al., 2006; Hua et al., 2013).  
As a drug delivery system, liposomes offer several advantages including biocompatibility, 
biodegradability, low toxicity, capacity for self-assembly, ability to trap both hydrophilic and 
lipophilic drugs, and a wide range of physicochemical and biophysical properties that can be 
modified to control their biological characteristics (Akbarzadeh et al., 2013). 
 
2.5.2.1  Preparation of liposomes  
There are several methods for the preparation of liposomes: thin film hydration method, ether 
injection method, reverse phase evaporation method, lyophilization method. The type of 
preparation method influences the properties of liposomes, including their shape, size, 
stability and drug loading efficiency (Akhtar, 2014). 
 
2.5.2.1.1   Thin-film hydration method 
One of the most widely used techniques for liposome manufacturing is the thin-film 
hydration or Bangham method. Briefly, as represented in figure 2.6, this method involves 
dissolving the lipids in an organic solvent, evaporation of the solvent under reduced pressure 
to produce a thin film of lipids, and the hydration of the obtained lipid film in aqueous media. 
The drug to be entrapped can be included in the aqueous media (for hydrophilic drugs) or in 
the lipid film (for lipophilic drugs). However, this method produces large and 
nonhomogeneous multi lamellar vesciles (MLVs) that require sonication or extrusion 
processes to produce homogeneous small unilamelar vesicles (ULVs) (Bozzuto et al., 2015). 
http://etd.uwc.ac.za/
 
 
19 
 
Figure 2-6: Liposomes manufacturing steps. (Source: Ghanbarzadeh et al., 2013) with some 
modification. 
 
2.5.2.2 Types of liposomes 
 Liposome size can vary from very small to large vesicles and may have one or bilayer 
membranes as depicted in figure 2.7. On the basis of their size and number of bilayers, 
liposomes can also be classified into one of two categories: (1) multilamellar vesicles (MLV): 
these vesicles have many bilayers and big in size and may be up to 5 μm and (2) unilamellar 
vesicles: these vesicle has a single phospholipid bilayer sphere enclosing the aqueous 
solution. Unilamellar vesicles can also be classified into three categories: (1) large 
unilamellar vesicles (LUV) with a size range from 100 to1000 nm and (2) small unilamellar 
vesicles (SUV) with sizes range of 20 to 100 nm (3) oligolamllar vesicles, these are made up 
of bilayers of lipids surrounding a large internal volume (Shashi et al., 2012).  
  
Figure 2-7: Classification of liposomes based on the lamellarity and size. (Source: 
Yingchoncharoen et al., 2016). 
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2.5.3 Phytosomes  
The term phyto means plant while some means cell-like (Sharma et al., 2016). Phytosome 
structures contain the active ingredients of the herb surrounded by the phospholipids. 
Phytosomes are advanced forms of herbal products that are better absorbed, utilized, and as a 
result produce better results than conventional herbal extracts (Shelke, 2012). Phytosomes 
protect valuable component of herbal extracts from destruction by digestive secretion, 
demonstrates better absorption which produces better bioavailability and improved 
pharmacological parameters than conventional herbal extracts (Pawar et al., 2015). In 
phytosomes, the complex of phospholipids and water soluble active plant components 
involve chemical bond formation and therefore becomes more stable (Nayyer et al., 2015). 
 
2.5.3.1 Difference between liposome and phytosome 
In principle, both liposome and phytosome systems are vesicular structures prepared by 
phospholipids and the fundamental difference between them is the way of drug incorporation 
in their structure. Phytosomes are not liposomes - structurally, the two are distinctly different 
as shown in figure 2.8. The phytosome is a unit of a few molecules bonded together, while 
the liposome is an aggregate of many phospholipid molecules that can enclose other 
phytoactive molecules but without specifically bonding to them (Rawat et al., 2012).   
 
Figure 2-8: Difference between phytosome and liposome. The molecular organization of 
phytosomes (lower segment) and liposomes (upper segment). (Source: Karimi et al., 2015).  
 
In liposomes the active ingredient is dissolved in the medium contained in the cavity or in the 
layers of the membrane, no chemical bond is formed; the phosphatidylcholine molecules 
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collectively surround the water-soluble substance (Rawat et al., 2012). There may be 
hundreds or even thousands of phosphatidylcholine molecules surrounding the water-soluble 
compound. In contrast, with the phytosome it is an integral part of the membrane, being the 
molecules anchored through chemical bonds to the polar head of the phospholipid. The 
phosphatidylcholine and the individual plant components actually a 1:1 or a 2:1 complex 
depending on the substance. Unlike liposome, chemical bonds are formed between 
phosphatidylcholine molecule and phytoconstituent, so the phytosomes show better stability 
profile (Rani et al., 2007).  
 
2.5.3.2   Preparation of phytosomes  
Phytosomes are formulated by the processes in which the standardized extract of active 
ingredient are bound to phospholipid like phosphatidylcholine (PC), 
phosphatidylethanolamin or phosphatidylserine through a polar end (Amit et al., 2013). 
Phytosomes are prepared by one of the following methods:  anti-solvent precipitation 
technique, rotary evaporation technique, solvent evaporation technique, ether injection 
technique (Udapurkar et al. 2016). 
In recent years, a variety of phospholipid-related formulations (phytosomes and liposomes) 
have been reported to increase the bioavailability of poor lipid soluble extracts by increasing 
the absorption in gastrointestinal tract. Phytosome has been effectively used to enhance the 
bioavailability of many popular herbal extracts or active molecules as Silybin, Ginseng, 
Grape seed, Curcumin and olive oil (Prasad et al., 2016; Dewan et al., 2016). Liposome has 
been effectively used to enhance the bioavailability of many popular herbal extracts or active 
molecules as Artemisia, Catechin, Querectine and Myrtus communis (Thapa et al., 2013; 
Sharma, 2014).  
 
2.5.4 Structural components of lipid based drug delivery systems 
There are a number of the structural and non-structural components of lipid based 
formulations. The major structural components of lipid based drug delivery system are:  
 
2.5.4.1   Phospholipids  
Phospholipids are amphiphilic molecules, consisting of hydrophobic tails and a hydrophilic 
head. The hydrophilic head contains the negatively charged phosphate group, and may 
contain other polar groups. The hydrophobic tail usually consists of long fatty acid 
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hydrocarbon chains (Suriyakala et al., 2014). When placed in water, they form various 
structures depending on their specific properties. Mostly, they form micelles or are organized 
as lipid bilayers with the hydrophobic tails lined up against one another and the hydrophilic 
head-group facing the water on both sides. Phospholipid molecule and its arrangement into 
the lipid bilayer structure are depicted in figure 2.9 and 2.10, respectively. 
 
Figure 2-9: A diagram showing a phospholipid molecule with two fatty acids and a 
modified phosphate group attached to a glycerol backbone. (Source: Boundless, 
2017).  
 
 
Figure 2-10: Illustration of the basic elements of a lipid, with the arrangement into 
the lipid bilayer structure. (Source: Boundless, 2017). 
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Glycerol containing phospholipids are most commonly used component of liposome 
formulation and represent more than 50 % of weight of lipid in biological membranes. These 
are derived from phosphatidic acid. The back bone of the molecule is the phosphoric ester of 
glycerol (Anwekar et al., 2011). One of the OH groups of phosphoric acid may be further 
esterified to a wide range of organic alcohols including glycerol, choline, ethanolamine, 
serine and inositol. Examples of phospholipids are phosphatidylcholine (PC), phosphatidyl 
ethanolamine (PE), phosphatidyl serine (PS), phosphatidyl inositol (PI), and phosphatidyl 
glycerol (PG) for stable liposomes, saturated fatly acids are used. Unsaturated fatty acids are 
not used generally (Anwekar et al., 2011). 
 
2.5.4.1.1 Phosphatidylcholine (PC) 
The commonly used lipid phase substances for producing liposomes and phytosomes are 
phospholipids from soy, and mainly phosphatidylcholine (PC) (Choubey, 2011). Soybean 
phosphatidylcholine (SPC) has been clinically available for several decades due to its 
biocompatibility, biodegradability, metabolic activity, and low toxicity compared to its 
synthetic alternatives. These abundant characteristics make SPC an attractive candidate for 
production of pharmaceutical dosage forms (Hou et al., 2012). 
Phosphatidylcholine is miscible in both water and lipid environment and well absorbed when 
taken orally. It has two polar and non-polar portions where, the polar head of PC, choline, 
interacts with phytoconstituents by creation of an H-band between phosphatidylcholine‘s 
phosphate group and hydroxyl group of phytoconstituents. Due to the chemical bond between 
the H-band of PC and phytoconstituents, phytosomes show better physical stability which 
enhances absorption of hydrophilic polar phytoconstituents resulted in enhanced 
bioavailability and greater therapeutic benefits (Bhattacharya, 2009).  
 
2.5.4.1.2   Lecithin  
Lecithin (phosphatidylcholine) is a generic term which is used to designate a yellow 
brownish fatty substance present in animal or plant tissue composed of phospholipids, 
phosphoric acid, triglyceride, glycolipids, etc. Lecithin is extracted from sources such as soya 
beans, eggs, milk, marine sources, rapeseed, cottonseed and sunflower chemically by using 
hexane, ethanol, etc. Lecithin has emulsification and lubricant properties (Tiwari, 2013).  
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2.5.4.2 Cholesterol  
The presence of cholesterol in the lipid bilayer enhances the stability and can be incorporated 
into phospholipid membranes in very high concentration up to 1:1 or even 2:1 molar ratio of 
cholesterol to phosphatidylcholine. The chemical structure of cholesterol is demonstrated in 
figure 2.11. Cholesterol inserts into the membrane with its hydroxyl group oriented towards 
the aqueous surface and aliphatic chain aligned parallel to the acyl chains in the centre of the 
bilayer. The high solubility of cholesterol in phospholipid liposome has been attributed to 
both hydrophobic and specific head group interaction (Anwekar et al., 2011). Cholesterol 
serves many biological functions. Cholesterol and its derivatives are included in the lipid 
bilayer membrane generally to reduce the fluidity or microviscocity of the outer membrane. 
Cholesterol alters the packing of phospholipid molecule in the structure, it enhances vesicle 
resistance capacity to form aggregates, decrease the permeability of the bilayer membrane to 
water soluble (hydrophilic) molecules and helps in the formation of a stable membrane in the 
presence of biological fluids such as plasma (Andhale et al., 2016). Liposomes without 
cholesterol are known to interact rapidly with plasma protein such as albumin, transferrin, 
and macroglobulin. These proteins tend to extract bulk phospholipids from liposomes, 
thereby depleting the outer monolayer of the vesicles leading to physical instability. 
Cholesterol appears to substantially reduce this type of interaction. Cholesterol has been 
called the mortar of bilayers, because by virtue of its molecular shape and solubility 
properties, it fills in empty spaces among the Phospholipids molecules, anchoring them more 
strongly into the structure (Patidar et al., 2015). 
 
Figure 2-11: General structure of cholesterol (Source: 
www.avantilipids.com). 
2.5.4.3    Stearic acid 
Stearic acid a charge inducer used to stabilize the bilayer membrane is often incorporated in 
lipid based formulation because they increase the surface charge density and prevent vesicle 
aggregation, flocculation and fusion. The net surface charge of liposome can be modified by 
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the incorporation of charge inducers such as stearic acid and other compounds such as 
stearylamine, cetylpyridinium chloride, sodium de oxycholate, phosphatidic acid and 
dicethylphosphate (Nimmathota, 2016; Junyaprasert et al., 2008; Khan et al., 2017; 
Thulasiramaraju et al., 2012). 
An appropriate selection of lipid vehicles, formulation strategies and rational delivery system 
design can lead to the success of lipid based drug delivery systems (Kalepu et al., 2013). 
 
2.5.5 Characterization of liposomes and phytosomes  
The behaviour of phytosomes in both physical and biological systems is governed by factors 
such as size, membrane permeability, percentage entrapped, chemical composition as well as 
the quantity and purity of the starting materials. Therefore, the phytosomes are characterized 
for physical attributes i.e. shape, size, its distribution, percentage drug capture, percentage 
drug release and chemical composition (Jain et al., 2010). In order to assess the liposome and 
phytosomes to obtain quantitative measures that allow comparison between different lipid 
vesicles formulations, various parameters can be examined.  
 
1) Morphology: The shape of lipid vesicles can be seen using Transmission and 
Scanning Electron Microscopy (TEM) and techniques (Ravi et al., 2015; Dewan et al., 2016). 
 
2) Particle size and size distribution: The improved drug bioavailability of 
nanoparticles is attributed to the fact that particles in the nano-size range are efficient in 
crossing permeability barriers (Pandey et al., 2005). The size of the vesicle governs the in 
vivo fate of lipid vesicles, because it determines the fraction cleared by the reticulo-
endithelial system (RES) (Sharma et al., 2016). Several techniques are available for assessing 
submicrometer size and polydispersity index which include microscopy techniques, size 
exclusion chromatography (SEC), field-flow fractionation and static or dynamic light 
scattering (Laouini et al., 2012). 
 
3) Zeta Potential: The zeta potential (ZP) indicates the overall charge a particle 
acquired in a specific medium. Stability of nanodispersion during storage can be predicted 
from the zeta potential value. The zeta potential indicates the degree of repulsion between 
close and similarly charged particles in the dispersion. High zeta potential indicates highly 
charged particles. Generally, high zeta potential (negative or positive) prevents aggregation 
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of the particles due to electric repulsion and electrically stabilizes the nanoparticle dispersion. 
On the other hand, in the case of low zeta potential, attraction exceeds repulsion and the 
dispersion coagulates or flocculates (Das et al., 2011). 
It is reported that microspheres with a zeta potential above (+/-) 30 mV demonstrates 
stabilization in suspensions (Kumar et al., 2010; Al-Shdefat et al., 2012). Zeta potential 
values and their related stability behaviour are illustrated in table 2.1 (Mayuri et al., 2016). 
 
Table 2.1: Standard zeta potential values and their related stability behaviour. 
Zeta potential (mV) Stability behaviour 
0 to ±5 Swift flocculation 
±10 to ±30 Initial instability 
±30 to ±40 Modest stability 
±40 to ±60 Fine stability 
More than ±61 Tremendous stability 
 
4) Encapsulation efficiency: The amount of drug encapsulated/entrapped in a lipid 
vesicle is given by the percent drug encapsulation. The first step for the determination of the 
encapsulation efficiency is the separation between the encapsulated drug (within the carrier) 
and the free drug (Laouini et al., 2012). Several separation techniques have been reported 
which include, column chromatography, dialysis membranes and ultracentrifugation. The 
ultracentrifugation technique is the most common as it is a simple and fast method for the 
separation of drug-loaded liposomes from their medium. 
 
5) Fourier transform infrared spectroscopy (FTIR): FTIR spectroscopy is a useful 
tool to determine the stability of phytosomes when dispersed in water. Complex formation 
can be confirmed by IR spectroscopy by comparing the spectrum of the lipid complex with 
the spectrum of the individual components and their mechanical mixtures. From a practical 
point of view, the stability can be confirmed by comparing the spectrum of the complex in 
solid form (phytosomes) with the spectrum of its dispersion in water after lyophilization, at 
different times (Sravanthi et al., 2013). 
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6) Release study: In vitro release studies are usually based on a dialysis method (Achim 
et al., 2009). No drug adsorption may occur and the membrane should be freely permeable to 
the active ingredient (the cut off molecular weight shouldn‘t be a limiting step in the 
diffusion process). The drug release from nanoparticles as represented in figure 2.12. This is 
either through bulk erosion in the matrix or by surface erosion in the polymer depending on 
the nature of drug and method of preparation adopted (Singh, 2015). 
 
 
Figure 2-12: Mechanism of drug release (a) Bulk erosion (b) Surface erosion (Source: Singh, 
2015). 
 
7) Stability study: During the development of liposomal/phytosomal drug products, the 
stability of the developed formulation is of major consideration. The therapeutic activity of 
the drug is governed by the stability of the lipid vesicles from the manufacturing steps to 
storage and delivery (Kalepu et al., 2013). A stable dosage form maintains the physical 
stability and chemical integrity of the active molecule during its developmental procedure 
and storage (Kalepu et al., 2013). 
 
2.6 Alginate coating 
Alginate is a naturally occurring hydrophilic biopolymer that is extracted from brown 
seaweed. It is polysaccharide which contains repeating monomeric units of 1, 4-linked a-L-
guluronic acid (G) and D-mannuronic acid (M) in blocks which are arranged in 
homopolymeric M blocks (MM) or homo-polymeric G  (GG) blocks interspersed with 
heteropolymeric (MG) blocks as depicted in figure 2.13 (Mandal et al., 2010).  
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Figure 2-13: Chemical structure of repeated units of alginate: D-mannuronic acid (M) and L-
guluronic acid (G). (Source: Daemi et al., 2012).  
 
Alginate is a versatile biopolymer, which has been extensively investigated and used for 
many biomedical applications, due to biocompatibility and biodegradability (Lee et al., 2012; 
Sun et al., 2013). In the presence of divalent cations such as calcium, binding to the negative 
charges of the G-blocks occurs, resulting in sodium alginate spontaneously crosslinking and 
forming a spherical hydrogel matrix with regular shape and size known as an alginate beads. 
The gelation and crosslinking of the polymer are mainly formed by chemical reaction. The 
calcium displaces the sodium from the alginate and holds the long alginate molecules 
together to form the characteristic egg-box structure shown in figure 2.14. Each alginate 
chain can dimerize to form junctions with many other chains and as a result gel networks are 
formed rather than insoluble precipitates (Jaiswal et al., 2009). Alginates have different 
affinity for divalent cations in an increasing manner as shown: Ca
2+ 
<Sr
2+
<Ba
2+
.  Calcium is 
the most frequently used cation to ionically cross-link alginate because it is considered 
clinically safe, easily accessible and economical (Reis et al., 2006).   
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Figure 2-14: Schematic crosslink between alginate and the calcium cations resulting in     ―egg 
box model" calcium cross-linked junctions. (Source:  Paques et al., 2014). 
 
Alginate bead coating is a microencapsulation technique used to improve the stability and 
bioavailability of products and control the rate of active agent release (Aizpurua-Olaizola et 
al., 2016). In the presence of divalent cations such as calcium, which bind to the alginate 
negative charges resulting in sodium alginate spontaneously crosslinking and forming a 
spherical hydrogel matrix with regular shape and size, to form what is known as an alginate 
bead. The main strengths of alginate devices are that it withstands the degradation by gastric 
acid and rapid erosion at neutral pH (d‘Ayala et al., 2008). 
Liposomes encapsulated within an alginate hydrogel have been formulated to overcome the 
problems of liposomes instability designed for oral consumption (Grijalvo et al., 2016). 
Alginate hydrogels have been used as oral delivery systems in the presence of acid 
environment of the gastrointestinal tract. Liposomal formulation entrapping manganese 
porphyrin (Mn-por), was protected from the gastrointestinal tract acid environment, and 
embedded in alginate hydrogel beads. Both alginate hydrogels and liposomes were able to 
maintain their physical properties under acidic pH, allowing the delivery of Mn-por to the 
intestine (Aikawa et al., 2015). 
Alginate beads are pH sensitive rendering it suitable for the intestinal delivery systems. When  
cross linked alginate matrix systems are exposed to low pH, it shrinks and the encapsulated 
drugs are not released, forming an insoluble alginic acid in the gastric environment. Once 
passed into higher pH of the intestinal tract, the alginic acid is converted to a soluble viscous 
Sodium alginate 
Cross linked calcium alginate 
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layer which results in faster degradation and release of molecules. This pH dependent 
behaviour of alginate can be exploited to customize release profiles (Wang et al., 2013; 
Mittal et al., 2016). 
 
2.6.1 Alginate hydrogel beads preparation 
Alginate hydrogels beads can be prepared by various cross-linking approaches, including: 
2.6.1.1 Ionic cross-linking 
The most common methods used to fabricate alginate gel beads employ external soluble ionic 
cross-linking agents, such as divalent cations (i.e. Ca
2+
). When a droplet of aqueous sodium 
alginate dripping from a needle tip and enters a CaCl2 bath, Ca
2+
 ions diffuse into the alginate 
rich droplet faster than the rate of diffusion of alginate molecules. This results in conversion 
of the alginate droplets to gel beads, kinetically entrapping the originally dispersed material 
in the alginate solution. The gelation and crosslinking of the polymers are mainly achieved by 
exchange of sodium ions from the guluronic acids with divalent cations, and the stacking of 
these guluronic groups to form the characteristic egg-box structure as represented in figure 
2.15 (Lee et al., 2012; Sun et al.,2013). 
 
2.6.1.2 Covalent cross-linking 
Covalently cross-linked hydrogels can be prepared from chemically modified alginates; a 
covalently cross-linked hydrogel is chemically stable and can provide different modes of 
stress relaxation. However, covalent cross-linking reagents may be toxic, and the unreacted 
chemicals may need to be removed from the gels. By covalently conjugating methacrylate 
groups onto the alginate backbone, covalently cross-linked hydrogels can be prepared in the 
presence of a photo initiator and UV light (Lee et al., 2012; Sun et al.,2013). 
   
2.6.1.3 Thermal gelation 
Thermo-sensitive hydrogels have been widely investigated in many drug delivery 
applications, due to their adjustable swelling properties in response to temperature changes, 
leading to on demand modulation of drug release from the gels (Lee et al., 2012; Sun et 
al.,2013). 
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Figure 2-15: Schematic representation of alginate beads fabrication process: step 1: bead 
production using a syringe; step 2 sieving of the beads out of the CaCl2 solution for washing and 
air drying (Source: Juárez et al., 2014). 
 
2.6.2 Physicochemical characterization of alginate hydrogels beads. 
The properties of beads prepared by ionotropic gelation are influenced by formulation and 
processing parameters (Smrdel et al., 2008). Various techniques have been employed for 
characterization of alginate hydrogel beads, which can be characterised for: 
 
1) Morphology  
External surface features like shape, smoothness and porosity are examined to see possible 
correlation with release behaviour and stability. This can be performed by scanning electron 
microscopy (SEM) after gold coating under vacuum (Ahmed et al., 2013). 
 
2) Particle size 
The common technique for analysis of alginate bead particle sizes is to use optical 
microscopy with a calibrated stage micrometer (Indira et al., 2012). The size of wet beads 
depends on the size of a droplet of polymer dispersion, which is influenced by diameter of the 
nozzle and viscosity of polymer dispersion. However, drying may influence the size and 
shape of dry beads (Smrdel et al., 2008). The size of alginate beads may also be affected by 
the concentration of alginate and calcium (Kaza et al., 2011). 
 
3) Percentage encapsulation 
The encapsulation efficiency is dependent on many factors which includes the type of drug, 
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polymer, concentration, additives, drug-polymer weight ratio as well as process variables 
such as hardening time, type and concentration of cross-linking agent (Smrdel et al., 2008). 
Low alginate concentration leads to a decrease in drug encapsulation efficiency due to less 
binding sites for Ca
2+
 ions resulting in the formulation of a less compact gel membrane which 
increases influx of Ca
2+
 ions (Kundu et al., 2012). Encapsulation also increases with an 
increase in calcium chloride as demonstrated by Rajesh et al., (2011) when increasing the 
concentration from 1 % to 2 %. 
 
4) Compatibility study  
The existence of a possible interaction between drug and the calcium alginate can be 
investigated by Fourier transform infra-red (FTIR) analysis (Mandal et al., 2010).  
 
5) Swelling index 
The degree of swelling in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF) 
can be indicative of the stability. Chan et al. (2007) reported alginate matrices demonstrate a 
pH-dependent hydration, swelling and erosion behaviour (Chan et al., 2007). Patel et al. 
reported that the sodium alginate beads exhibited pH-dependent swelling with lowest 
swelling ratio in pH 1.2 and showed disintegration in pH 7 to 7.5 within 45 to 50 min. This 
can be explained by the presence of ion exchange between Ca
2
+ ion in the hydrogel and Na+ 
ions in phosphate buffer (Patel et al., 2006).  
 
6) In vitro release and mechanism of release studies 
Release from alginate network depends on various parameters, including particle size, 
hydrogel mesh size, and hydrophilicity of the incorporated drug, as well as the composition 
of the particle and hydrogel (Buwalda et al., 2017). 
Mechanisms for drug release from a particle embedded in hydrogel beads are depicted in 
figure 2.16. It can be either via release of the drug from the entrapped particles and 
subsequent drug diffusion through the polymer matrix of the hydrogel (figure 2.16, top), .This 
can also be via the slow release of drug loaded particles from the hydrogel and subsequent 
release of the drug from nano particles (figure 2.16, bottom) or via a combination of these 
mechanisms (Mokale et al., 2014).  
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Figure 2-16: Schematic representation of two mechanisms for drug release from a particle 
embedded in a bead: (top) release of the drug from the entrapped particles and subsequent 
drug‎diffusion through the polymer matrix of the hydrogel; (bottom) release of drug entrapped 
particles from the beads and subsequent release of the drug from the nano particles. (Source, 
Mokale et al., 2014).  
 
The release of active compounds from matrix beads is pH dependant as reported by Sizery et 
al. (Suzery et al., 2017) Their study demonstrated that alginate beads prevented phycocyanin 
release in simulated gastric fluid medium (acidic environment). Hence, after 2 hours of 
incubation, there was no release of phycocyanin in the simulated gastric fluid medium but it 
released rapidly in the simulated intestinal fluid medium. It has been reported that the release 
of drug from alginate gel beads is due to diffusion through the swollen matrix and relaxation 
of the polymer at pH 1.2 to 4.5 and due to the diffusion and erosion mechanism at pH 7–7.5 
(Takka et al., 1998). 
 
2.6.3 Biomedical applications of Alginate beads                                                 
Calcium alginate gel beads have been developed as a unique vehicle for drug delivery and 
successfully used as a matrix for the entrapment and/or delivery of biological agents. Various 
categories of drugs and biomolecular chemicals have been encapsulated. These include 
nonsteroidal anti-inflammatory drugs, enzymes, peptides/proteins, and acid labile drugs 
(Nimase et al., 2010; Babu et al., 2007). Alginate has been widely used in a variety of 
biomedical applications, including cell encapsulation, cell transplantation tissue engineering 
and drug delivery (Baniasadi et al., 2015). Alginate beads have been used to encapsulate 
other delivery systems including microspheres and liposomes (Gombotz et al., 2012). It has 
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also been used for stability improvement of various compounds and oral bioavailability issues 
(Sankalia et al., 2005; Bhushan et al., 2015; Lin et al., 2016; Davidov-Pardo et al., 2014). In 
addition, alginate has been used as gastro resistant carrier (El-Sherbiny et al., 2011; Cerciello 
et al., 2016; Smith et al., 2010; Aikawa et al., 2015).  
Alginate-liposome systems have been used for release profile modification (Dhoot et al., 
2003; Nagpal et al., 2012). Combinations of liposomes and alginate have been investigated in 
order to modify the release of drugs from such phospholipid vehicles and to stabilize the 
products (Tønnesen et al., 2002). The release of nicardipine HCl was extended by employing 
calcium alginate gel beads (Takka et al., 1998) and liposome-loaded calcium alginate 
microspheres have also rendered controlled release properties to resveratrol (Balanč et al., 
2016).  
 
2.7 Response surface methodology 
The design of experiments is a structured, organized method used to determine the 
relationship between the factors affecting a process and the output of that process (Shaji et 
al., 2016).  In the development of any pharmaceutical product an important issue is to design 
a formulation with optimized quality in a short time period and minimum number of trials. 
Among diversity of DOE techniques, Response Surface Methodology (RSM) is the most 
frequently used optimization technique for designing and optimization of different 
pharmaceutical formulations, which requires minimum experimentation. Thus, it is less time-
consuming and cost-effective compared to conventional methods of formulating dosage 
forms (Mishra et al., 2016). 
The response surface methodology (RSM) is a collection of mathematical and statistical 
techniques useful for modelling and analysis of problems, in which an output variables of 
interest is influenced by several input variables and the objective is to simultaneously 
optimize the levels of these output variables to attain the best system performance. The 
design based on fit of a polynomial equation to the experimental data for empirical model 
building. An experiment is a series of tests, called runs, in which changes are made in the 
input variables in order to identify the reasons for changes in the output response 
(Ashengroph et al., 2013). It is a useful tool for studying the influence of experimental 
parameters by varying them simultaneously and for determining experimental factor 
settings and assesses the relationship between experimental and observed results to find the 
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optimum conditions for a reaction using a limited number of experiment runs to obtain 
statistically acceptable results (Khajeh, 2012).  
RSM has several advantages compared to the classical experimental or optimization methods 
in which one variable at a time technique is used. Firstly, RSM trims down the number of 
experimental runs that are necessary to establish a mathematical trend in the experimental 
design region allow to determining the optimum level of experimental factors required for a 
given response, RSM offers a large amount of information from a small number of 
experiments. Secondly, in RSM it is possible to observe the interaction effect of the 
independent parameters on the response. The model equation easily clarifies these effects for 
binary combination of the independent parameters. In addition, the empirical model that 
related the response to the independent variables is used to obtain information about the 
process. With respect to these, it can be said that RSM is a useful tool for the optimization of 
chemical and biochemical process (Singh et al., 2014; Ghanbarzadeh et al., 2014). 
Recently, RSM has been extensively applied for the optimization of multiple variables in 
many bioprocesses and showed satisfactory results; it has been used for optimization of lipid 
vesicles formulation (Soema et al., 2015; Wang et al., 2014). 
 
2.7.1 Definition of terms in RSM 
There are some important terms which describes the response surface methodology to a 
greater extent, which include the following: (1) Experimental domain is the experimental 
field that must be investigated. It is the minimum and maximum limits of the experimental 
variables studied. (2) Experimental design is a specific set of experiments defined by a matrix 
composed by the different level combinations of the variables studied. (3) Input variables are 
experimental variables that can be changed independently of each other. Typical independent 
variables comprise the pH, temperature, reagent concentration etc. (4) Levels of a variable are 
different values of a variable at which the experiments must be carried out. (5) Responses or 
output variables are the measured values of the results from experiments. Typical responses 
are the analytical signal (absorbance, intensity, etc.). (6) Residual is the difference between 
the calculated and experimental result for a determinate set of conditions. A good 
mathematical model fitted to experimental data must present low residuals values (Bhan, 
2017). 
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2.7.2 Process for RSM application  
Steps invlved in the application of the response surface methodology as an optimization 
technique include: Selection of input and output factors of major effects on the system; 
choice of the experimental design and performing the experiments according to the selected 
matrix; measurement of output variables and mathematic–statistical treatment of the obtained 
experimental data through a polynomial function fit; Evaluation of the model fit; Verification 
of the necessity and possibility of performing a displacement in direction to the optimal 
region; and Obtaining the optimum values for each studied variable (Bezerra et al., 2008; 
Shivakumar et al., 2007). 
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Chapter 3                                    
Methodology 
 
3.1       Preparation of freeze dried H. procumbens plant extract 
H. procumbens coarse powder was purchased from (Warren Chem, South Africa). Five 
hundred grams of plant powder was macerated in 2000 ml distilled water in a 2500 ml glass 
container and tightly closed to prevent water evaporation. The container was agitated in a 
shaker (Labcon, USA) at 40 
o
C for 6 hours, followed by separation of the macerate using a 
porcelain funnel. This was filtered using Whatman no. 1 filter paper and centrifuged with a 
(Beckman Coulter, USA) centrifuge for 30 min at 10, 000 rpm. The resultant supernatant was 
carefully removed and collected. The supernatant was transferred into aliquots of 500 ml 
round bottom flasks and sealed. The flasks were carefully filled with liquid nitrogen until 
completely frozen. The containers   were connected to a freeze dryer (Virtis 
®
, UK) and dried 
under low pressure. The macerate was freeze dried for 2 days and 18 hours. The final 
powdered product was carefully collected and stored in air tight containers, in a freezer 
(Mahomed et al., 2006).  
 
3.2      Identification of harpagoside biomarker in plant extract  
3.2.1 LC/MS  
Liquid chromatography/mass spectrometry (LC/MS) analysis method was used as it offers a 
good combination of sensitivity and selectivity (Lei et al., 2011). Prepared freeze dried plant 
extract contains many active ingredients and harpagoside was used as marker compound 
(Mncwangi et al., 2014; Karioti et al., 2011). LC/MS was used to identify the marker 
compounds (harpagoside) in the plant extract via exact mass of the compound. 
 
3.2.1.1   Instrumentation 
For identification purposes, spectrometric analysis was carried out on reconstituted freeze 
dried plant extract in distilled water solution recorded mass spectrum was compared to 
reference standard compounds of harpagoside in methanol using single quadrupole mass 
spectrometry (Perkin Elmer SQ 300 MS. USA) equipped with electrospray ionisation (ESI) 
source with operated mode at a voltage of 50,000 V.   
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3.2.1.2    Method 
Direct Infusion Electrospray Ionization (DI-ESI- (+) method was used. Reference standard of 
harpagoside and plant extract sample solutions were filtered through 0.2 syringe filter 
(solution A). Solution A was added to 50 % aqueous methanol (MS grade, Merck, South 
Africa) as diluent containing 0.1 % formic acid, which enhances sample ionization, (solution 
B). Fifteen microliters of solution B were directly infused into the ESI chamber of the SQ 
300 mass spectrometer using the on-board syringe pump at the rate of 15 µl/min and the ions 
were detected in positive and negative modes, i.e. ESI-MS (+/-), scan spectra from 100 to 
2000 m/z was used. The mass spectra were collected and analysed using the Chromera
® 
manager V 3.4.4.5945 software. The harpagoside qualitative peak in the plant extract was 
therefore correlated to the MS spectrum of the reference standard compound. 
 
3.2.2 UHPLC  
The biomarker compound was further identified by the spiking method using UHPLC. Pre- 
analysed plant extract samples were spiked with definite concentration of standard 
harpagoside and injected into the UHPLC. The subsequent peaks height was measured and 
compared i.e. before after spiking.  
3.2.2.1    Development and validation of an UHPLC method for harpagoside 
An isocratic HPLC method adapted from (Babili et al., 2012) with slight modification was 
utilized.  
 
3.2.2.2    Instrumentation  
Ultra-high performance liquid chromatography (Perkin Elmer, USA) was equipped with a 
programmable Flexar FX-15 auto sampler, a UHPLC pump model FX-15, and a Flexar PDA 
plus detector model FX-15 and Flexar solvent manager 3-CH degasser was used. The data 
were recorded using Chromera
® 
Manager software version 3.4.4.5945. 
 
3.2.2.3     Chromatographic Conditions 
The following chromatographic conditions were used with a Kinetex150 x 4.6 mm, 5 um C-
18 column: Flow rate: l ml /min, injection volume: 10 µl, wavelength: 278 nm, column 
temperature: 25 °C, auto sampler tray temperature: 4 °C, run time: 5 min, diluent: mobile 
phase 60:40% v/v methanol HPLC-grade methanol (Sigma Aldrich, South Africa) and 
deionized water (18 MΩ·cm) was obtained by water filtration system (O purity, SA), 
http://etd.uwc.ac.za/
 
 
35 
acidified with 0.1 % formic acid formic acid (Merck, South Africa),. Elution mode: isocratic, 
detector:  UV/ PDA plus. 
 
3.2.2.4    Preparation of pure standard harpagoside stock solution 
One milligram of pure standard harpagoside purchased from (Sigma Aldrich, South Africa) 
was accurately weighed using semi micron electronic balance (Shimadzu, Japan) and 
transferred to a 1ml volumetric flask. This was dissolved in 1 ml of methanol, vortexed for 30 
seconds using vortex mixer (Benchmark, Taiwan) and the solution filtered through 0.25 μm 
syringe filter (KimLab, India) prior to performing HPLC analysis.  
 
3. 2. 2. 5       Preparation of mobile phase 
Filtered and degassed mobile phase consisting of solvent A: deionized water acidified with 
0.1 % formic acid and solvent B: methanol at the selected ratios was utilized. All solvents 
were ﬁltered through filter apparatus (Millipore ®, USA) using 0.25 µm membrane filter 
(Millipore, Ireland). 
 
3.2.2.6      Key parameters of the analytical method validation 
The UHPLC method was validated to assure the method appropriateness for the quantitative 
analysis of harpagoside marker compound in plant extract. The validation method met the 
International Conference on Harmonization guidelines (ICH, 2005). The following analytical 
parameters were used: a) Specificity b) Linearity. c) Accuracy. d) Precision (repeatability, 
intermediate precision). e) Sensitivity. g) Robustness. h) System suitability. 
 
a) Specificity 
It is the ability to detect the analyte uniquely in the presence of other components (ICH, 
2005). Specificity was evaluated by means of analysis of the mobile phase, (Methanol: 
Water) by injection to determine if there was any interference with harpagoside elution.   
Specificity was confirmed by the base hydrolysis test by force degrading the test sample in an 
alkaline medium. One millilitre of sodium hydroxide solution (0.1 M) ( B & M Scientific, 
SA) was added to 9 ml of harpagoside solution, vortexed to disperse the sodium hydroxide 
solution uniformly in the test sample and allowed to stand for 24 hours, then analysed 
(Bhimavarapu et al., 2011).  
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b) Linearity  
Linearity of an analytical procedure is its ability (within a given range) to obtain test results 
which are directly proportional to the concentration of analyte in the sample (ICH, 2005). 
Linearity was evaluated by linear regression analysis method using a calibration graph. The 
calibration curve was obtained by plotting the peak area versus injected analyte concentration 
from six different duplicate concentrations ranging from 0.125(100 %), 0.0625(50 %) 
0.03125(25 %), 0.01562(12.5 %), 0.00781(6.25 %), 0.003905(1.56 %) and 0.00195(3.125 %) 
mg/ml. These were prepared from a standard harpagoside stock solution. The correlation 
coefficient, y-intercept and slope of the regression line were calculated.  
 
c) Precision 
The precision of an analytical procedure expresses the closeness of agreement between 
results obtained from multiple samplings of the same homogeneous samples under prescribed 
conditions (ICH, 2005). Precision of the developed method was studied under the headings of 
repeatability (intra-day precision) and intermediate precision (inter-day precision). The 
repeatability was assured by six replicates of 0.125 mg/ml of harpagoside standard solution. 
The intermediate precision was evaluated by analysing three replicates of harpagoside 
standard solution at three concentration levels (0.125, 0.0625, 0.03125 mg/ml), on three 
different days.  The average, standard deviation and relative standard deviation (coefficient of 
variation) of the replicates were calculated for each type of precision from the peak area of 
harpagoside. 
 
d) Accuracy 
The accuracy of an analytical procedure expresses the closeness of the test results obtained by 
the method and the value found (ICH, 2005). The accuracy was assessed by determining the 
percentage recovery of the known amount of standard harpagoside at six replicates of the 
level 0.01562 mg/ml and then the individual and mean percentage recovery were calculated 
using the following formula:  
Recovery (%) = (m measured / m calculated) × 100.                               Eq 1. 
Where m measured is the harpagoside amount measured and m measured is the calculated 
amount of harpagoside obtained from the calibration curve (Babili et al., 2012). 
http://etd.uwc.ac.za/
 
 
37 
e) Sensitivity 
Limit of Quantitation is the lowest amount of analyte in a sample which can be quantitatively 
determined with suitable precision and accuracy. Limit of detection is the lowest amount of 
analyte in a sample which can be detected but not necessarily quantitated as an exact value 
(ICH, 2005). 
 
Limit of Detection (LOD) and Limit of Quantitation (LOQ) were determined using the 
calibration curve method. The LOD and LOQ of the assay method were evaluated based on 
the standard deviation of the response and the slope by using linearity data of serial dilutions 
of harpagoside stock solutions. The values of the slope and the standard deviation of the y-
intercepts of the regression line were used to calculate the LOD and LOD of the proposed 
method and were calculated using the following equations: 
 
                                                     LOQ = 10 × 
 
S
 .                                                                Eq 2. 
 
                                                     LOD = 3.3 × 
 
S
 .                                             Eq 3. 
Where   = the standard deviation of the response. 
           S = the slope of the calibration curve. 
The slope S was estimated from the harpagoside calibration curve. The standard deviation of 
y-intercepts of regression line was used as the standard deviation. 
 
f) Robustness 
Robustness of an analytical procedure is a measure of its capacity to remain unaffected by 
small, but deliberate variations in method parameters (ICH, 2005). It was evaluated by 
applying the developed method while introducing variations, wavelength was altered to (± 2), 
column temperature was changed to (± 2 °C) units from set value, and the effect of these 
variations was recorded. 
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g) System suitability 
The purpose of the system suitability test is to ensure that the complete testing system is 
adequate for the intended analysis. For system suitability, six replicates of (0.125 mg/ml) 
pure standard harpagoside were injected into UHPLC and column performance factors 
namely; theoretical plate count, tailing factors, resolution, and retention time were 
determined. 
3.3 Quantitative determination of harpagoside constituent in H. procumbens plant 
extract 
The concentration of harpagoside in the freeze dried plant crude extract was determined by 
applying the validated UHPLC method on a reconstituted solution of freeze dried plant 
extract in distilled water. The obtained peak area was interpolated to concentration utilizing 
the generated calibration curve. The experiment was repeated three times and results 
presented as microgram per milligrams of dry weight ± standard deviation.  
 
3.4 Lipid vesicles (liposomes and phytosomes) preparation 
 
3.4.1    Preparation of 0.1 M potassium phosphate buffer pH 7.4 at 25 °C 
 1M K2HPO4 at 174.18 g mol-1 = 87.09 g per 1 L. 
 1M KH2PO4 at 136.09 g mol-1 = 68.045 g per 1 L. 
Added 80.2 ml of K2HPO4 to 19.8 ml of KH2PO4, dilute the combined 1M solutions to 1 
litre distilled water (Cold spring harbor protocols). 
 
3.4.2    Liposome preparation 
Conventional lipid thin film hydration technique as described by Sha et al., (2012) with slight 
modifications was used. The liposomes synthesis method consisted of three steps: 
 
Step-1: Drying the lipid phase 
The lipid phase components, i.e., L-a Soy phosphatidylcholine (PC) (> 95 % purity) (Avanti 
® polar lipids.Inc. USA) and cholesterol (≥ 99 %) (Sigma Aldrich, USA) were weighed using 
an analytical balance (Mettler, USA) and dissolved in 2 ml chloroform (Merck.SA); Once the 
lipids were thoroughly mixed in the organic solvent , the mixture was transferred to a round-
bottom flask and attached to a rotary evaporator (Buchi-RII Rotavapor, Switzerland) attached 
to a vacuum pump (Buchi V-700, Switzerland). The round-bottom flask was immersed in a 
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thermostatic water bath, evacuated and rotated at 150 rpm, at 45 °C; the chloroform was 
evaporated under vacuum to yield a lipid film. The process was allowed to continue 1 hour to 
affirm the dryness of the lipid film deposited on the walls of the flask. The flask was sealed 
with parafilm to prevent humidity entrance to the flask and stored for at least 24 hours at – 20 
C.    
 
Step-2: Hydration of dry lipid film. 
The residual lipid film was hydrated with the aqueous phase which consisted of crude plant 
extract dissolved in 5 ml phosphate buffered solution (PBS) pH 7.4.  The mixture was shaken 
in a mechanical shaker (Labcon, USA) for 1 hour at 300 rpm and  temperature above the 
transition temperature (Tm) of L-α Soy phosphatidylcholine which is ≈ 39 C                          
( Süleymanoglu, 2009). The suspension was subjected to five freeze-thaw cycles to produce 
multi-lamellar vesicles (MLV). The round bottom flask containing the liposomal suspension 
was placed in ice bath for 5 min and directly transferred to a hot water bath for another 5 min. 
The freeze-thaw procedure reduces the lamellarity of the vesicles and is an important step to 
enhance the percentage of encapsulation efficiency values.  
 
Step-3: Homogeneity and Size reduction  
Large unilamellar vesicles (LUV) were obtained by extruding the MLV using a manual mini 
extruder (Avanti Polar Lipids, Inc., USA). The extruder was placed on a hot plate to raise its 
temperature above the phase transition temperature of PC. The liposomal suspension was 
passed through polycarbonate membranes five times with  1 ml Hamilton glass syringes to 
generate a homogeneous LUV population (Ong et al., 2016). 
 
3.4.3    Phytosomes preparation 
Phytosomes were prepared by thin lipid film hydration technique previously reported by Saha 
et al., (2013). The same steps to prepare liposomes were followed.  The only difference was 
that freeze dried plant extract was added to the lipid phase components in step one. General 
steps of liposomes and phytosomes preparation by thin film hydration method are shown in 
figure 3.1. 
http://etd.uwc.ac.za/
 
 
40 
   
  a-Lipid mixture homogenization b-Transfer into round bottom 
flask 
c- Solvent evaporation 
  
d- Hydration and mechanical 
shaking 
e- Extrusion 
Figure 3-1 : General lipid vesicles preparation. 
 
3.5 Physicochemical characterization of H. procumbens liposomes and phytosomes 
 
3.5.1     Visualization of lipid vesicles by optical microscopy 
Preliminary lipid vesicle formation upon hydration was confirmed by optical microscopy. 
This involved  placing, a drop of lipid vesicles suspension  on a glass slide without a cover 
slip, and observing the lipid vesicles  through a vertical optical microscope (Zeiss, Germany) 
at 40X magnification using a differential interference contrast (DIC) objective (Bibi et al., 
2011). 
 
3.5.2   Mean particle size and polydispersity index (PDI) determination 
Knowledge of liposomes and phytosomes size and polydispersity is important for quantitative  
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interpretation of results. Particle size is determined by dynamic light scattering based on the 
principle of the random Brownian motion of particles in a liquid is faster for small particles 
than for large particles.  
The mean particle size (z-average diameter) of the liposomes and phytosomes was 
determined. To measure the level of homogeneity of particle sizes of the liposomes and 
phytosomes, the mean particle size (z-average diameter) and polydispersity index (PDI) was 
measured using photon correlation spectroscopy (PCS) using a Nano ZS 90 Zetasizer 
(Malvern Instruments Ltd., U.K.) with the 4 mW He–Ne laser operating at a wavelength of 
633 nm, temperature of 25 °C and a 90 o scattering angle. One millilitre of phytosomal or 
liposomal suspension was loaded into a zeta-potential measurement capillary cell (DTS 
1070), the capillary cells were thoroughly rinsed with deionized water before filling to avoid 
any contamination. Three independent measurements for ten cycles were performed for each 
sample. The z-average diameter and the polydispersity index of the liposomes were 
automatically generated by the instrument using cumulant analysis with software loaded   the 
instrument. 
3.5.3     Zeta potential determination 
 The zeta potential is a function of the surface charge of the suspension or dispersion (Demir 
et al., 2014). The charge present on the surface of colloid particles was measured using the 
Smoluchowski‘s equation from the electrophoretic mobility of liposomes and phytosomes. 
The same instrument was used for this as for particle size measurement i.e. Zetasizer Nano 
ZS 90 at 25 °C with a voltage of 4 mV.  The samples were analysed at 25 ºC at an angle of 
173 to the laser beam. The intensity-weighted mean value was measured and the average of 
three measurements taken. 
The measurement was conducted after filling 1 ml of each liposomal and phytosomal 
dispersion into the zeta-potential measurement capillary cell (DTS 1070), the capillary cells 
were thoroughly rinsed with deionized water before filling with liposomes or phytosomes 
solution to avoid any contamination. Three independent measurements for ten cycles were 
performed for each sample (Saoji et al., 2016). 
 
3.5.4    Percentage entrapment efficiency  
Encapsulation efficiency (% EE) was evaluated by determining the content of plant extract 
encapsulated (using harpagoside as the marker) into the liposomes and phytosomes. This 
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involved two steps (Begum et al., 2012). 
 
Step one:    Harpagoside starting concentration determination 
In case of liposomes, the starting concentration was determined by using a 1ml sample from 
the aqueous phase which consisted of plant aqueous solution dissolved in phosphate buffer 
before hydration, filtered through 0.45 µm nylon syringe filters (kimLab, India) with the 
sample analysed by UHPLC. In the case of phytosomes, because the crude extract is 
integrated in the thin film formation process, the phytosomes had to be disrupted for 
harpagoside detection. One millilitre of ethanol (Merck .SA) was added to 1 ml phytosomal 
suspension and sonicated for 3 min to break the phytosomes using a probe tip sonicator 
(Bandelin Sonoplus, Germany). This was followed by centrifugation using an ultra-centrifuge 
(Eppendorf 5417 R, Germany) at 10, 000 rpm for 5 min at 4 °C and filtration through 0.45 
µm syringe filter.  The sample was analysed using UHPLC. 
 
Step 2:  Encapsulated harpagoside concentration determination 
a- Lipid vesicles purification: interference of free harpagoside with encapsulated 
harpagoside detection was avoided by a separation technique. 1ml of H. procumbens 
loaded liposomes or phytosomes dispersion was transferred via pipette to a 2 ml 
eppendorf tube and centrifuged using an ultra-centrifuge, at speed of 10,000 rpm for 1 
hour at 4 °C in order to separate unloaded harpagoside by the formation of 
supernatant and a pellet. The formed pellet which comprised the liposome or 
phytosomes was double washed with PBS, where 1 ml PBS was added to the pellet 
and vortexed for 20 seconds to disperse the vesicles and dissolve the free harpagoside 
in the PBS and centrifuged again at the same speed and time. 
 
b- Pellet lysing and content analysis: after washing steps, 1 ml ethanol was added to 
the pellet to lyse the lipid vesicle to liberate the entrapped harpagoside. This mixture 
was sonicated by using a probe tip sonicator. The sonicator tip was inserted in the 
eppendorf tube and sonicated for 3 min at high intensity. The mixture was centrifuged 
and filtered using a 0.45 um filter; the entrapped harpagoside was determined by 
UHPLC. The percentage encapsulation efficiency (% EE) was expressed as the 
percentage of the encapsulated harpagoside concentration to the total, as follows:  
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                                                           % EE = 
C1
C2
 x 100.                                                    Eq 4. 
Where C1 represents the drug content in the pellet, C2 is the total drug content added 
to the formulation. 
 
3.6 Preliminary study for determination of nano lipid vesicles formulation 
parameters 
Preliminary studies were performed on the lipid vesicles to ensure vesicle formation, plant 
extract encapsulation and characterization. This was done before using experiment design 
software for optimized nano formulation. 
 
3.6.1     Investigating the effect of lipid type on percentage encapsulation efficiency 
Various  trial batches of lipid vesicles were prepared as presented in table 3.1 with diversity 
in lipid type i.e. lecithin (Sigma aldrich) and L-a Soya phosphatidylcholine, on the basis of 
most commonly used, compatibility with plant extract, and lipid vesicle formation. 
Subsequent determination of percentage encapsulation efficiency was performed as stated in 
section 3.5.4. 
Table 3.1: Lipid vesicles formulations with diversity in lipid type 
Batch.no 
Cholesterol 
w/w 
Lecithin 
w/w 
Plant extract 
w/w 
Phosphatidylcholine 
w/w 
L1 1 / 5 9 
L2 1 9 5 / 
 
3.6.2     Investigating the optimal sonication time for vesicle disruption 
Lecithin was excluded from further experiments as it demonstrated low percentage 
encapsulation efficiency from previous preliminary experiments and all further formulations 
were prepared with PC as the main lipid component in the formulation.  
Lipid vesicles were formulated at a ratio of 5:9:01 w/w plant extract, cholesterol and PC, 
respectively. Four samples of 1ml each were centrifuged to pelletize the prepared vesicles, 
double washed with PBS and 1ml ethanol was added to each sample. Samples were sonicated 
using a probe tip sonicator, each of which was subjected to definite time of sonication 1, 2, 3, 
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4 min. The samples were centrifuged, filtered through 0.45 µm syringe filters and UHPLC 
analysed to determine harpagoside concentration after disruption with ethanol and sonication. 
3.6.3    Investigation of the influence of lipid vesicle size reduction process on the 
percentage encapsulation efficiency 
Lipid vesicles were formulated at a ratio of 5:9:01 w/w plant extract, cholesterol and PC, 
respectively. Three methods for vesicle  size reduction  were used i.e. probe sonication using 
a probe sonicator, water bath sonication using an ultra-sonic bath (Labotec, South Africa) and 
extrusion using an extruder. Samples from the 3 methods were analysed for particle size 
(section 3.5.2) and percentage encapsulation efficiency (section 3.5.4) by zeta-sizing and 
UHPLC, respectively. 
3.6.4 Finding the appropriate plant extract ratio for appropriate percentage 
encapsulation efficiency 
Lipid vesicles were prepared with different plant extract quantities to get an indication of the 
most suitable quantity to use for optimal percentage encapsulation efficiency. Various 
batches as demonstrated in table 3.2 were prepared and lipid vesicles were disrupted by 
adding ethanol and the percentage encapsulation efficiency was determine by applying the 
steps stated in section 3.5.4. 
Table 3.2: Lipid vesicle formulations prepared with constant lipid phase content and 
variation in plant extract content for investigation of the percentage of encapsulation 
efficiency values divergence. 
Lipid vesicle formulation Plant extract: Phosphatidylcholine: Cholesterol 
L1 2.5:9:01 
L2 5:9:01 
L3 10:9:01 
 
3.7 RSM optimization process of nano lipid vesicles formulation by design of 
experiments  
In the development of any pharmaceutical formulation an important issue is to design a 
formulation with optimized quality in a short time period and minimum number of trials. The 
response surface methodology has been commonly used for designing and optimization of 
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different pharmaceutical formulations, which requires minimum experimentation (Malakar et 
al., 2012). Thus, it is less time-consuming and more cost-effective than the conventional 
methods of formulating dosage forms.  
This methodology could be employed to optimize lipid vesicles formulations (liposome and 
phytosome) components for high encapsulation. RSM was used to optimize the particle size 
and percentage encapsulation efficiency of lipid vesicles using lipid content (PC and 
cholesterol) and vesicle type (liposome/phytosome) as effective variables. 
 
3.7.1 Generating experimental matrix 
RSM optimal design was employed for the optimization of H. procumbens plant extract nano 
formulation (liposome and phytosome) using Design-Expert
® 
software version 8.0.7.1 (Stat 
Ease Inc., USA).  Numerous variables may affect the response of the liposome formulations. 
It is practically very difficult to identify and control the small contributions from each one 
Bezerra et al., 2008). Therefore, three important process parameters including initial (
concentrations of PC (A),  cholesterol (B), as well as vesicle type (liposome/ phytosome) (C) 
were used and optimized as input factors to obtain the best response of particle size (Y1PS), 
polydispersity index (Y2PDI) and the percentage encapsulation efficiency (Y3%EE). These 
were used as output factors. The input factors were evaluated at two levels, the higher and 
lower levels of each factor are presented in table 3.3. 
 
Table 3.3: The upper and lower levels of input factors set for optimization process. 
Input  factor Name Lowe level Upper  level 
A Phosphatidylcholine (%wt ) 10 80 
B Cholesterol (% wt) 5 40 
C Vesicle type  Liposome phytosome 
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The RSM optimal design building outcome was 17 runs which varied between liposomes and 
phytosomes formulations with different composition as represented in table 3.4. 
 
Table 3.4:  Generated experimental matrix by RSM optimal design. 
 
 
3.7.2 Lipid vesicle characterization of RSM generated experiments 
The 17 different runs of liposomes and phytosomes were carried out according to the 
components ratio proposed by the design software using thin lipid film hydration technique 
as described in section (3.4.2 and 3.4.3). Liposomal and phytosomal preparations were 
characterized for vesicle size, polydispersity index and percentage encapsulation efficiency. 
After this the experimental results for each output factor were fitted in the design matrix. 
 
3.7.3  RSM Data analysis and evaluation of the fitted response surface models 
The output variables were fitted to a second order model in order to correlate the output and 
input variables. The general form of the second polynomial equation is as follows: 
  y = b0 +b1A +b2B +b3C +b4A
2 
+b5 B
2 
+b6 C
2 
+b7AB +b8AC+b9BC.                         Eq 5. 
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Where, y is the output variable, b0 is an intercept and b1–b9 are the regression coefficients. A, 
B and C represent the main effects, A
2
, B
2
 and C
2 
the quadratic effect, and AB, AC, and 
BC are the interaction effect.      
Regression analysis of the data was carried out using the Design-Expert
® 
software version 
8.0.7.1 (Stat Ease Inc., USA). One-way ANOVA was applied to estimate the significance of 
the model (P < 0.05) for individual output parameters. After ANOVA analysis, the Y3 full 
model was found not to be significant and the   model was reduced using the model reduction 
method. ANOVA was also performed to identify the significance of single factors in relation 
to their influence on the responses.   Each factor was considered to be significant when the p 
value was < 0.05. The adequacy of model was checked by accounting for R
2
, adjusted-R
2
 and 
comparing lack of fit p- values for each response. 
 
3.7.4 Formulation optimization using desirability function 
The desirability function approach is a technique for the simultaneous determination of 
optimum settings of input variables that can determine optimum performance levels for one 
or more responses (Mourabet et al., 2014).  In this study, the numerical optimization 
technique which represents the closeness of a response to its ideal value (Raissi et al., 2009) 
was adapted to optimize the process conditions of formulation variables (A; particle size, B; 
polydispersity index and C; percentage encapsulation efficiency) that provide desired 
outcomes for all responses. The desired goals known as constraints for each output and input 
factors were chosen along with the weighting and importance allocated for each goal as 
illustrated in table 3.5. All the independents variables were kept within range while the 
responses were either maximized or minimized. 
 
Table 3.5.: Desirability specifications of numerical optimization for H. procumbens nano 
formulation. 
Name 
  
Goal Lowe Upper  Lower  Upper  Importance 
    
limit Limit weight weight 
  Phosphatidylcholine (% wt ) is in range 10 80 1 1 / 
 Cholesterol (% wt ) 
 
is in range 5 40 1 1 / 
 Vesicle type 
 
is in range liposome phytosome 1 1 / 
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Vesicle size (nm) 
 
minimize 207.8 608.7 1 1 ** 
 Polydispersity index 
 
minimize 0.18 0.593 1 1 ** 
 Percentage encapsulation efficiency (%) maximize 2 31.25 1 1 **** 
  
3.7.5    Validation of optimized condition 
The optimum values of the selected formulation and its predicted output factors values were 
verified experimentally. Four replicates of the optimized phytosomes formulation were 
produced and the output factor values (particle size, polydispersity index, and percentage 
encapsulation efficiency) were experimentally determined. The model predicted values were 
compared with actual ones obtained from experimentation and the percentage error was 
calculated by using the following formula (Ghanbarzadeh et al., 2013): 
 
                                  % Error =     
Predicted - observed
Observed
   × 100                              Eq 6. 
 
3.8 Characterization of selected optimized RSM formulation 
 
3.8.1 Particle size and polydispersity index 
The optimized RSM phytosomes formulation was characterized for mean particle size and 
polydispersity index using the Zetasizer Malvern instrument as per method in section 3.5.2. 
 
3.8.2 Zeta Potential Analysis 
The optimized RSM phytosomes formulation was also characterized for zeta potential 
although it was not one of the output factors as per method in section 3.5.3. 
 
3.8.3 Surface Morphology 
The Scanning Electron Microscope (SEM) was utilized to study the external morphology of 
the phytosomes produced from the optimized formulation. Approximately 5μL of the 
phytosomal suspension was placed on double-sided carbon conductive adhesive tape fixed on 
SEM aluminium stubs.  The samples were allowed to dry at room temperature.  The 
phytosomes were then sputter-coated with a thin layer of gold in vacuum for 30 seconds at 20 
mA using a coating unit (Emitech K550X, England) to make it electrically conductive. The 
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surface morphology of the coated samples was viewed and photographed using an Auriga 
HR-SEM F50 scanning electron microscope (Zeiss, Germany) (El-Gazayerly et al., 2014). 
 
3.8.4 Apparent solubility study 
To determine the change in solubility due to complexion, a protocol reported by Tan et al., 
(2012) was followed. Solubility characteristics of H. procumbens extract and prepared H. 
procumbens phytosomes were determined by adding excess of the samples to 6 ml of water 
and n-octanol in a sealed glass container at room temperature. The liquids were shaken for 24 
hours and centrifuged at 4000 rpm for 10 min. The supernatant was filtered through a 0.45 
μm syringe filter, and analysed using UHPLC. 
 
3.8.5 FTIR spectroscopy  
To study the possible interactions between plant extract and phospholipids, IR spectrums of 
freeze dried H. procumbens plant extract, empty phytosomes, loaded H. procumbens 
phytosomes, were recorded in range of 4000 – 650 cm-1 using a Fourier transform infrared 
spectrometer (Perkin-Elmer Spectrum-400, USA) equipped with a diamond attenuated total 
reflectance (ATR) accessories with a diamond crystal. 
After fresh preparation of the phytosomal suspensions (empty and loaded), the  residual 
moisture in the samples was removed by subjecting the samples to vacuum drying using a 
vacuum oven before obtaining any spectra (Niive, lasec, South Africa). A small quantity of 
the sample was placed on the crystal, pressure applied and scanned at 2 cm⁻1/sec 4 times at a 
resolution of 4 cm⁻1/sec, the obtained IR spectra were interpreted for functional groups at 
their respective wave number (cm
-1
). The analysis of the spectra was done using spectrum 
software version 6.3.5.  
 
3.8.6 Stability in simulated gastric fluid (SGF) pH 1.2 
The selected optimized H. procumbens phytosomes formulation was evaluated for in vitro 
physicochemical stability after exposure to simulated gastric fluid (SGF; pH 1.2) by 
monitoring the physicochemical properties (particle size, polydispersity index, and zeta 
potential) of the prepared phytosomes  and compared with the initial values and physical 
changes (aggregation and precipitation) that  were seen with  H. procumbens phytosomes.  
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3.8.6.1 Preparation of simulated GI media  
Simulated intestinal fluid and gastric fluid as media were used to conduct the stability study 
as per WHO (WHO, 2012) guidelines. The simulated gastric fluid (SGF) was prepared by 
dissolving 2.0 g of sodium chloride in 7.0 mL of hydrochloric acid (420 g/l) and made up to 
1000 ml with water. SLS (0.1 %) was added as surfactant to simulate the gastric conditions. 
This test solution had a pH of 1.2.  
 
3.8.6.2 Method 
Physical changes of H. procumbens phytosomes in simulated GI media and the possible 
corresponding correlation of these changes with the phytosomes stability was investigated. 
The method reported by Freag et al., (2013) was used with some modifications. H. 
procumbens phytosomes were prepared and purified by the centrifugation technique as stated 
in section (3.5.4, step 2 a). One millilitre of the phytosomal formulation was added to 2 ml 
SGF at pH 1.2 in 10 ml glass vials tightly closed with plastic caps. The vials were incubated 
for 2 hours.The samples were thereafter mildly agitated at 75 rpm on a digital multi-position 
magnetic stirrer (VELP Scientifica, Europe), and heated at 37 °C in the circulating 
thermostatic bath (Julabo5B, Germany). Empty phytosomes were prepared following the 
same steps and exposed to SGF. This served as the control. 
At two hour intervals, samples of empty and loaded phytosomes were assessed for the 
physicochemical properties such as particle size, zeta potential as well as polydispersity index 
and harpagoside content in the medium, using the Zetasizer and UHPLC. Experiments were 
performed in duplicate.   
 
3.9 Phytosomes in alginate system 
One of the key features of an oral delivery system for H. procumbens phytosomes should be 
the ability to transit through stomach with minimal impact from the adverse gastric 
environment. 
 
3.9.1 Preparation of the alginate coated H. procumbens phytosomes  
The alginate coated H. procumbens phytosomes were prepared using the inotropic gelation 
technique by the syringe method as reported by Bansal et al., (2016) with slight 
modifications, in attempt to increase the H. procumbens phytosomes stability in the gastric 
environment. 
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i. Preparation of sodium alginate stock solution 
Concentrated sodium alginate was prepared by weighing the corresponding amount (1, 2 and 
4 mg) of sodium alginate powder (Merck, South Africa) and dissolved by sprinkling the 
powder in a 200 ml beaker with 90 ml distilled water. This was placed on a magnetic stirrer 
(500 rpm) at 60 °C for 2 hours to ensure complete dissolution of the powder. The solution 
was left to cool to room temperature (Abdalla et al., 2015). 
 
ii. Preparation of Calcium Chloride Solution (cross linking agent) 
Calcium chloride solution was prepared by mixing (2 and 4 mg) (Merck, South Africa) in 100 
ml of distilled water and stirred until complete solution. 
 
iii. Addition of H. procumbens phytosomes to the alginate solution 
Freshly prepared H procumbens phytosomes were pelleted by centrifugation, washed twice to 
separate un-encapsulated plant extract and re-suspended in distilled water. Ten millilitres of 
pure H. procumbens phytosomal suspension was mixed with 90 ml sodium alginate to obtain 
a final concentration of (1, 2 and 4 %).  The dispersion was then stirred slowly for 10 min for 
equal dispersion of the phytosome in the polymer (sodium alginate) solution.  
 
iv. Dropping of H. procumbens phytosomes - alginate solution into CaCl2 solution 
Bubble free H. procumbens phytosomes-alginate solution was added drop wise in a 50 ml 
measuring cylinder had 50 ml of aqueous calcium chloride solution (cross-linking agent), via 
an insulin syringe filled by 5 ml syringe with sodium alginate-phytosomes solution, kept at 
25 
o
C and stirred slowly at 400 rpm for 15 min, to enhance the rigidity, mechanical strength 
of the beads and also to prevent aggregation of the formed beads. The distance of the needle 
from the cross linking solution was 5 cm, the droplets from the drug-polymer dispersion 
instantaneously gelled upon contact with the calcium chloride solution which acts as a cross-
linking agent and small beads formed as shown in figure 3.2. 
After 15 min of curing, the obtained beads were harvested by filtering through a Whatman

 
filter paper, washed thoroughly with distilled water to remove any traces of crosslinking 
agent from the beads. The beads were collected on a petri-dish and air dried for 36 hours at 
room temperature and stored in an air-tight container.  
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A) Dropping B) Curing C) Washing 
  
A) Washing B) Obtained dried - fresh beads 
Figure 3-2: Preparation of alginate coated H. procumbens phytosomes beads 
by ‎ionotropic ‎gelation ‎method.‎ 
 
3.9.2 Process variables and optimization  
The ability of beads to entrap the phytosomes is the determining factor for selection of 
composition of the beads. Accordingly, preliminary work on the preparation of alginate 
beads was performed to investigate the contribution of formulation parameters on the bead 
size and ease of preparation, entrapment efficiency and release profile of H. procumbens 
phytosomes from alginate beads (output factors). Input factors such as concentration of 
sodium alginate and of calcium chloride were chosen to optimize the beads composition 
because they play a vital role in achieving high entrapment efficiency, proper particle size, 
swelling behaviour, and surface morphology (Patel et al., 2016).  
Six sets of empty and alginate coated H. procumbens phytosomes were prepared  using 
different sodium alginate and calcium chloride concentrations., The sodium alginate factor 
was evaluated at three different concentrations (Singh et al., 2012) and calcium chloride  at 
two concentrations (table 3.6). The other variables that are thought to have effect on the bead 
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character such as, stirring speed of the cross linking solution, was kept constant at 400 (Al-
kassas et al., 2007). The needle distance from the cross linking solution was 5 cm (Jahan et 
al., 2010). The volume of cross linking solution was kept constant to exclude any source of 
variability. Formulations were analysed for all determined output factors. 
 
Table 3.6: Composition of alginate coated H. procumbens phytosomes formulations 
Batch Code 
 
Sodium Alginate 
(%w/v) 
Calcium Chloride 
(%w/v) 
F1 1 2 
F2 2 2 
F3 4 2 
F4 1 4 
F5 2 4 
F6 4 4 
 
 
3.9.3 Characterization of alginate coated H. procumbens phytosomes 
 
 
3.9.3.1    Particle size measurements 
The particle size of empty and alginate coated H. procumbens phytosomes was measured 
using a light microscope (Nikon, Japan). Randomly selected beads were placed on a clean 
glass slide. The diameter of 10 randomly selected beads was measured at a 40X 
magnification. The instrument eyepiece was calibrated at 1 unit equal to 0.0256 mm. The 
average sizes of 10 beads were determined for each formulation using the calibration factor; 
all measurements were in triplicate the average diameter of the beads was calculated using 
the following formula (Patel et al., 2016). 
                                                       X = ∑ ( Xi )  ∕  N                                                           Eq 7. 
 
 Where, X = Average particle diameter, Xi = individual diameter of beads and    N = number 
of beads. 
 
3.9.3.2    Percentage encapsulation efficiency determination 
Alginate coated H.procumbens phytosomes (100 mg) were dispersed in a glass vial 
containing 2 ml PBS (pH 7.4) and sonicated for 10 min. The mixture was vigorously stirred 
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at 1000 rpm for 4 hours with a magnetic stirrer to break down the alginate coating (Nayak et 
al., 2011). One ml of ethanol was added and the mixture was probe sonicated for 3 min to 
lyse the H. procumbens phytosomes liberated from lysed alginate beads. The mixture was 
centrifuged for 5 min, filtered through 0.45 µm syringe filter and analyzed using UHPLC. 
Observations were recorded in triplicate and the beads percentage encapsulation efficiency 
was calculated using following formula (Kassem et al., 2012): 
 
           Percentage encapsulation efficiency  = 
Entrapped drug 
Initial drug 
  100                              Eq 8.          
 
3.9.3.3    Alginate coated H. procumbens phytosomes erosion study 
An erosin study was performed to determine how alginate and calcium chloride concentration 
affects the time needed for alginate beads to swell, disintegrate and release their encapsulated 
phytosomes. Equal amounts of dried alginate beads were dispersed in glass vials containing 
phosphate buffer solution pH 7.4 in equal volumes and placed in multi positions of a 
magnetic stirrer water bath at 37 
o
C and 100 rpm for 2 hours. Alginate coated H. procumbens 
phytosomes integrity was visual inspected and released plant extract was detected by UHPLC 
at time interval of 1, 2, 4, 6 & 8 hours. 
 
3.9.3.4   Morphology and surface assessment of selected alginate coated H. procumbens 
phytosomes 
Morphological examination of the surface of the dried alginate coated H. procumbens 
phytosomes was carried out using a scanning electron microscope. Randomly selected beads 
were placed on double-sided copper conductive tape fixed on aluminium stubs. The beads 
were then sputter-coated with a thin layer of gold in a vacuum for at 20 mA using a coating 
unit to make it electrically conductive and was analyzed with a SEM instrument. 
 
3.9.3.5   Phytosomes- polymer compatibility study  
H. procumbens phytosomes- alginate polymer interactions in the formulation were studied by 
the use of the Fourier Transform Infrared (FTIR) spectrometer. Empty and loaded alginate 
beads (alginate–coated H. procumbens phytosome) were prepared and air dried. H. 
procumbens phytosomes were prepared and dried in a vacuum oven at room temperature.  
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The samples were put on the small diamond crystal and pressure was applied by ATR 
accessory and scanned 4 times at 2 cm⁻1/sec at a resolution of 4 cm⁻1/sec within the wave 
number range of 4000 cm-1-650 cm
-
1. Drug polymer interaction was studied by comparing 
the IR spectra of H. procumbens phytosomes and empty alginate beads with H. procumbens 
phytosomes loaded alginate beads. The analysis of the spectra conducted used spectrum 
software version 6.3.5. 
 
3.9.3.6   Swelling index study  
This study was conducted to estimate the percentage swelling of the alginate beads. This is 
responsible for leaching of the phytosomes into the gastric and intestinal fluids. The beads 
swelling extent in the dissolution medium was determined by following described methods 
by Patel et al., (2016; Nayak et al., (2011). The extent of swelling was measured in terms of 
% weight gain by beads. The swelling behaviour of dried beads in gastric and intestinal 
simulated fluids (SGF; pH 1.2, SIF; pH 7.4) was tested. Simulated gastric fluid prepared as 
prescribed in section (3.8.6.1), simulated intestinal fluid (SIF) was prepared as per WHO 
(WHO, 2012); 6.8 g of potassium dihydrogen phosphate was dissolved in 250 ml of water 
and 190 ml sodium hydroxide (0.2 mol/l) and 400 ml water. The resulting solution was 
adjusted with sodium hydroxide (0.2 mol/l) to a pH of 7.5 ± 0.1 and diluted with sufficient 
water up to 1000 ml. 
In this test 3.4 mg of optimized alginate–coated H. procumbens phytosomes formulation was 
transferred to a glass vial containing GSF. The samples were stirred at 60 rpm speed in a 
multi stirrer water bath and allowed to swell for 2 hours at 37 ± 0.5 °C in simulating the 
gastric medium. The same experiment was repeated in SIF. At the end of 2 hours, the beads 
were withdrawn, placed on tissue paper to remove moisture adhering to the surface and 
immediately weighed. The swelling behaviour of beads was expressed as the ratio of initial 
weight of beads to the final weight of swollen beads as a function of time.  
The % weight gain by the beads (swelling index) was calculated by the following formula:  
 
                           Swelling index (SI) = [{Wt – W0}/ W0] x 100.                                  Eq 9.                  
 
Where, Wt = Mass of swollen beads at time t and W0= Mass of dry beads at t = 0. 
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3.9.3.7   Invitro drug release in GIT fluids 
The release study was performed at different pH (SGF; 1.2, SIF; 7.4), simulating transition of 
beads in GIT; the media of pH 1.2 was representing the gastric condition pH 7.4 was 
representing the intestinal condition. 
 Accurately weighed 10 mg of alginate coated H. procumbens phytosomes was dispersed in a 
10 ml glass vial containing 2 ml simulated intestinal fluid (SIF) and placed in a multi stirrer 
water bath its temperature was adjusted to 37 
o
C and 200 rpm. The experiment was conducted 
for 8 hours. One vial was used for each time point. (1, 2, 4, 6, and 8 hours).  At the 
determined time interval the vial was removed from the water bath and the solution was 
transferred by pipette to eppendorf tubes. This was centrifuged for 30 min at 14,000 rpm. The 
supernatant was filtered through 0.45 µm syringe filter and UHPLC was used for the analysis 
to quantify the harpagoside released from alginate coated H. procumbens phytosomes. The 
experiment  was repeated using simulated gastric fluid (SGF) as release medium for 4 hours, 
The experiments were done in duplicate (Shazly et al., 2008) with slight modification.  
 
3.9.3.8   Release profile determination 
The drug release study was performed by using the dispersion method reported by Shazly et 
al., (2008) with slight changes on selected optimized H. procumbens phytosomes 
formulation, alginate coated H. procumbens phytosomes formulation and freeze dried extract 
to compare the release pattern in PBS pH 7.4 as release medium. Five mg of freeze dried H. 
procumbens extract was placed in 10 ml glass vials containing 2 ml release medium. These 
were placed in a circulating thermostatic water bath on digital multi-position magnetic stirrer. 
The temperature was set at 37 C and stirring speed of 200 rpm for 8 hours. A different vial 
was used for each time interval.  After the specific time interval, a vial was removed; the 
solution filtered, and analyzed using UHPLC, to quantify harpagoside concentration in the 
release medium. Experiments were performed in duplicate.  The same steps were applied for 
the H. procumbens phytosomes and alginate coated phytosomes, but firstly the phytosomes 
were purified by centrifugation as mentioned in section (3.5.4) to prevent un-encapsulated 
harpagoside from being present in the release medium and influencing the result. The purified 
phytosomes were re-suspended in PBS and used to conduct the release study.  
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3.9.3.9   Mechanism of rlease 
The analysis of the mechanism of drug release from the pharmaceutical dosage form is an 
important process. In order to understand the mechanism and kinetics of drug release, 
the drug release data of the in-vitro  study was fitted to various kinetic equations such 
as zero-order, first-order, Higuchi and the Korsmeyer and Peppas equation (Mello et al., 
2011) The DDSolver 1.0 software was used for the linear regression analysis. It features 40 
models that can be used to directly calculate the parameters and the appropriateness of each 
model. Correlation coefficient correlation values were calculated for the linear curves 
obtained with regression analysis. The value of the release exponent (n) of the Korsmeyer–
Peppas equation was determined and used to indicate different release mechanisms. The 
highest values of regression coefficient (R2) were selected as the best fit model. The 
equations used for calculating the release kinetics are as follows:  
 
 Zero Order model:                                         F=k0*t                                            Eq.10                  
Where F denotes fraction of drug released up to time t, ko is the zero-order rate constant 
expressed in units of concentration/time, t is the time in hours. 
 First Order model:                                        F=100*[1-n (-kf*t)]                         Eq.11                  
Where  kf is the constant of mathematical model.  
 Higuchi’s‎model                                            F=kH*t1/2                                                               Eq.12                 
Where kH is the constant reflecting the design variable of the system.  
 Korsmeyer-Peppas model:                          F=kK-P*t^n                                        Eq.13               
Where kK-P is the rate constant and n is the release exponent. 
 
 
3.9.3.10    Effect of storage temperature on H. procumbens phytosomes and alginate coated 
phytosomes. 
Phytosomes were stored for 30 days at 4-8 °C (refrigerated temperature), 25 °C, and 37 °C. 
Freshly prepared phytosomes were purified to separate of non-entrapped harpagoside by 
centrifugation method. Purified phytosome formulations were placed in glass vials, tightly 
sealed and parafilmed. Sample aliquots were withdrawn periodically at 1, 7, 14, 30 days.  
Particle size, polydispersity index, zeta potential and harpagoside leakage analysis were 
evaluated using a zetasizer and UHPLC as the method described by Muppidi et al., (2012).    
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For leakage analysis samples were centrifuged and the supernatant was injected into UHPLC 
to detect and quantify the harpagoside leaked from phytosomes.  
 
For alginate coated H. procumbens phytosomes, the method reported by Kashid et al., (2016) 
was used with slight modifications. These were also tested for stability. A 50mg of dried 
alginate coated H. procumbens phytosomes were transferred to air tight containers, 
parafilmed and stored at 4-8 °C, 25 °C and 37 °C for 30 days. At predetermined time of 1, 7, 
14, 30 days samples were analysed for particle size to check for possible changes in the bead 
size due to temperature variation. The samples were tested for harpagoside leakage. Samples 
were transferred to 2 ml tubes; 1ml ethanol was added and stirred slowly for 10 min. The 
ethanol was added to dissolve any phytosomes which may have migrated from the alginate 
core to the shell. Ethanol does not affect the alginate bead integrity. 
 
3.10   Statistical analysis of data  
All results were expressed as mean values ± standard deviation (SD). The results were 
evaluated and analyzed statistically with the GraphPad InStat
®
 software (version 6, Graph 
Pad Software San Diego, California, USA). Analysis of variance (ANOVA) was used to 
assess regression analysis R
2
 (correlation coefficient) and linear regression to measure 
linearity. Data was analyzed for one and two way analysis of variance (ANOVA). One-way 
ANOVA analysis was followed by the Tukey‘s multiple comparison test. A probability factor 
of less than 0.05 (P < 0.05) was considered to represent statistically significant difference, 
whereas P < 0.001 was considered extremely significant. 
Design-Expert®, version 8.0.7.1 software (Stat-ease Inc., USA) was used for performing 
experimental design, polynomial fitting and ANOVA results.  
DDsolver software for model fitting for release study data and evaluation of release kinetics 
was obtained according to exponent release value. 
http://etd.uwc.ac.za/
 
 
59 
Chapter 4                                  
Results and discussion 
 
4.1  H. procumbens plant extract preparation 
Freeze dried H. procumbens plant extract was prepared by maceration of coarse plant powder in 
water followed by freeze-drying and solvent elimination under reduced pressure. This produced 
a light-brown, powdery crude extract which was stored in the freezer at -20 
o
C in an air tight 
container.   
 
4.2  Identification of harpagoside biomarker in H. procumbens plant extract  
 
4.2.1  LC/MS 
The detection was performed by means of electrospray ionization mass spectrometry in negative 
and positive ion mode. Positive identification of harpagoside in plant extracts was accomplished 
by analysis of peaks using mass spectrometry (MS)-detection. Figure 4.2, 4.4 show the full scan 
mass spectra obtained by direct infusion of the test sample solution in the electron spray 
ionization (ESI) positive and negative ion mode respectively, following careful comparison of 
harpagoside ESI /MS spectra in H. procumbens plant extract with pure standard harpagoside 
(figure 4.1, 4.3). In the ESI negative ion mode, the fragmentation pathways are different from 
those obtained in the positive ion mode.  
In the positive ion mode, as can be seen in figure 4.1, the pure standard harpagoside spectrum 
characterized by the presence of fragment ion of 517 [M+Na]
 + 
corresponding to sodium ion 
adduction as the base peak of harpagoside and the same corresponding fragment ion at m/z 517 
was seen in H. procumbens extract as demonstrated in figure 4.2 (the arrow refers to the 
harpagoside fragment ions). 
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Figure 4-1: full scan MS spectrum of pure standard harpagoside in positive ion mode showing [M+Na]
+
 
Ion  of harpagoside at m/z 517. 
               
 
Figure 4-2: full scan MS spectrum of plant extract in positive ion mode showing [M+Na]
+
 Ion 
of  harpagoside at m/z 517. 
 
In the negative ion mode, as can be seen in figure 4.3; the pure standard harpagoside spectrum 
was observed as molecule with attached negative formic acid ions [M+HCOO]
 -
 at m/z 539.23 as 
the base peak of harpagoside and the same corresponding fragment ion at m/z 517 was seen in H. 
procumbens extract as demonstrated in figure 4.4 (the arrow refer to the harpagoside fragment 
ions). Karioti et al. demonstrated [M+HCOO] - ion for harpagoside at m/z 539.23 in the negative 
mode and fragment ions of 517 [M+Na] + for harpagoside in the positive mode (Karioti et al., 
2011). 
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Figure 4-3: full scan MS spectrum of pure standard harpagoside in negative ion mode showing 
[M+HCOO]
 -
 Ion of harpagoside at m/z 539.23. 
 
 
Figure 4-4: full scan MS spectrum of plant extract in negative ion mode showing [M+HCOO]
-
 Ion 
of  harpagoside at m/z 539.23.‎ 
 
4.2.2 UHPLC  
For confirmative identification of harpagoside in plant extract, UHPLC was performed. Pre 
analysed plant extract sample represented in figure 4.5.1 was spiked with pure standard 
harpagoside; the blue peak demonstrates the harpagoside peak in H. procumbens plant extract 
before spiking. 
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Figure 4-5-1: Harpagoside chromatogram in plant extract before spiking.‎ 
 
Figure 4.5.2; represents the increasing harpagoside peak i.e. the blue peak height in the shown 
UHPLC chromatogram of plant extract after being spiked with pure standard harpagoside 
confirming the identity of the compound in the crude plant extract. The UHPLC method was 
used for identification and quantification of harpagoside in this thesis.        
 
 
Figure 4-5-2 : Harpagoside chromatogram in plant extract after spiking. 
 
UV spectrum analysis was performed for pure standard harpagoside in figure 4.6 (top) and the 
corresponding UV spectrum was obtained, which confirmed the identification of the harpagoside 
peak as depicted in figure 4.6 (bottom) when compared to harpagoside reference spectra from 
literature. 
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Figure 4-6 : Spectra for pure standard harpagoside peak at 278 nm indicating harpagoside identity     
and no co elution with harpagoside from other plant extract components. 
 
4.2.2.1    Development of an UHPLC method for harpagoside assay 
Utilizing the chromatographic conditions in the method mentioned in the experimental section 
produced peak eluted at 3.6 min retention time  in a run time of 5 min as can be seen in figure  
4.7 (blue peak represent harpagoside peak). 
 
 
Figure 4-7:  UHPLC chromatogram of pure harpagoside. Mobile phase (methanol: water; (60:40v/v). 
 
These optimal chromatographic conditions were employed for H. procumbens plant extract and 
produced the same peak at same retention time (3.6 min) as the pure harpagoside (figure 4.7) 
with good resolution and selectivity of harpagoside in plant extract as indicated in figure 4.8 
(The blue peak indicating harpagoside peak).  
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Figure 4-8 : UHPLC chromatogram of harpagoside in H. procumbens plant extract. 
 
The corresponding UV spectrum of the harpagoside peak in H. procumbens plant extract at 
retention time of (3.6 min) recorded at absorption maximum (278 nm) is represented in figure 
4.9 (arrow - harpagoside peak and corresponding UV spectrum). 
 
 
Figure 4-9:  Identical spectra (bottom) acquired across the harpagoside peak in plant extract (top) 
indicate  a pure peak of harpagoside at 3.6 min and showing no co elution with harpagoside at 278 
nm  from other plant extract components.  
 
 
The UV spectrum of harpagoside in the extract and that of the standard harpagoside was the 
same and in agreement to the UV spectrum reported by Li et al., (1999) and Wagner et al., 
(2011). 
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4.2.2.2  Validation UHPLC method of harpagoside  
1. Specificity 
Analysis of mobile phase did not create any interference with harpagoside elution, as 
demonstrated in figure 4.10.1 which is methanol chromatogram indicating that there was no peak 
eluted at harpagoside retention time (3.6 min) and figure 4.10.2 which is deionized water 
chromatogram showing also no peak eluted at harpagoside retention time (3.6 min).   From this 
result it was found that suitability of mobile phase system to perform UHPLC analysis for 
harpagoside. 
 
 
Figure 4-10-1: Mobile phase component (methanol) chromatogram. 
 
 
Figure 4-10-2: Mobile phase component (deionized water) chromatogram. 
 
 
http://etd.uwc.ac.za/
 
 
66 
To ensure specificity of the method the harpagoside was placed in 0.1 M sodium hydroxide. This 
degraded sample of harpagoside reflected a lower harpagoside peak height due to decrease in the 
analyte concentration as a result of degradation compared with non-degraded harpagoside 
sample peak, which illustrate the specificity of the method to detect the harpagoside even when it 
is degraded. Figure 4.11.1 illustrates non-degraded harpagoside (blue peak) and figure 4.11.2 
illustrates degraded harpagoside (blue peak). The proposed method passed the specificity test 
successfully. 
 
 
Figure 4-11-1: UHPLC chromatogram of pure standard non-degraded harpagoside.  
 
 
     Figure 4-11-2: UHPLC chromatogram of the forced degradation harpagoside sample in NaOH.  
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2. Linearity 
Linearity was measured using calibration plot of peak area against harpagoside concentration in 
a concentration range of 0.250 (100 %), 0.125 (50 %), 0.0625 (25 %), 0.03125 (12.5 %), 0.0039 
mg/ml (1.56 %) as depicted in figure 4.12.1. The slope, Y-intercept and correlation coefficient of 
the calibration curve were calculated by analysis of the regression line and the linear graph with 
linear equation Y= 7.849e + 006 X ‒ 135.3 was obtained. X is the concentration in mg/ml and Y 
is the peak area in absorbance units. A correlation coefficient of 0.9995 was obtained indicating 
good linearity correlation between the concentration peak area in the proposed range as it meets 
the acceptance criteria for linearity which is not less than 0.990 (Al-Rimawi, 2014).  
 
H arp a go s id e  co n cen tra tio n  (m g /m l)
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0 .0 0 .1 0 .2 0 .3
0
5 0 0 0 0 0
1 0 0 0 0 0 0
1 5 0 0 0 0 0
2 0 0 0 0 0 0
2 5 0 0 0 0 0
Y = 7.849e+006*X - 135.3
R
2
  =  0 .9 9 9 5 .
 
Figure 4-12-1 : Linearity plot of harpagoside dissolved in methanol. 
 
Another calibration curve was performed of harpagoside utilizing the same concentrations and 
different solvent of phosphate buffer (PBS) solution. It was used for harpagoside concentration 
calculation when the sample matrix is PBS. The linear equation of Y= 8.062e +006X ‒ 995.8  
was obtained for this calibration curve and had a correlation coefficient of 0.9992 which 
indicates the acceptable linearity between the concentration and peak area in the proposed range 
as represent in figure 4.12.2.  
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Figure 4-12-2: Linearity plot of harpagoside dissolved in phosphate buffer solution, 
pH  7.4.    
      
3. Intra-day precision (repeatability) 
Six harpagoside standard samples were used for this test each containing 62.5 µg/l. The 
percentage relative standard deviation was calculated and the results of the precision study are 
tabulated in table 4.1. 
 
                            Table 4-1: Intra-day precision (repeatability)   
Sample Peak area 
1 510971.39 
2 527050.87 
3 509822.10 
4 514614.35 
5 511100.73 
6 508643.31 
Average 513700.46 
SD 6839.4681 
% RSD 1.3314117 
 
The predetermined criterion for intra-day and inter-day precision is the percentage relative 
standard deviation of areas from 6 preparations. The precision level should not be more than 2.0 % 
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(Venhatesh et al., 2010).  The obtained result (1.33 %) was within this specification that 
indicates the analytical method is precise within the tested range. 
 
4. Intermediate precision 
Intermediate precision of the method was evaluated by calculating the percentage recovery of 
harpagoside at 3 concentration levels (0.125, 0.0625, 0.03125 µg/ml), over 3 days. The 
percentage relative standard deviation was calculated and the results of study are tabulated in 
table 4.2.                                                                                                                                          
                                  Table 4-2: Intermediate precision  
 0.125 mg/ml 0.0625 mg/ml 0.03125 mg/ml 
Day1 1010935.1 510971.4 336194.28 
Day2 1008195.7 529051.46 326897.81 
Day3 1005117 514470.47 324072.35 
Average 1008082.6 518164.44 329054.8 
SD 2910.6984 9589.3844 6342.302 
% RDS 0.2887361 1.8506450 1.92743 
 
The low % RSD of the 3 concentrations were (0.28, 1.85 and 1.92) which demonstrated that the 
UHPLC method is precise as the results were not more than 2 % (Venhatesh et al., 2010). 
 
5. Accuracy 
Accuracy was calculated by the recovery method from 6 replicates at the concentration level of 
0.0625 mg/ml. Accuracy was based on ratio of the measured quantity to the calculated quantity. 
The percentage relative standard deviation was calculated and the results are tabulated in table   
4. 3. 
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          Table 4-3: Percentage recovery of the harpagoside  
Measured conc. (mg/ml) Calculated conc. (mg/ml) Recovery % 
0.0625 0.0642 103.44 
0.0625 0.0662 105.93 
0.0625 0.0645 103.21 
0.0625 0.0651 104.19 
0.0625 0.0646 103.47 
0.0625 0.0643 102.97 
Average 0.0649 103.87 
 
As per International Council for Harmonisation (ICH, 2005) guidelines, pre-specified limits 
recovery should be within 95 % - 105 %. In the present study the percentage mean recovery of 
the 6 replicates of test concentration was (103.87 %) and therefore passed the accuracy test 
(Venkatesh et al., 2010). 
 
6. Specificity: 
Limit of detection and Limit of quantification of harpagoside investigated in this study using the 
current method were found to be low i.e. 0.0057 µg/ml and 0.0120 µg/ml, respectively. This 
shows the detection and quantitation of this compound at low concentration levels. 
 
7. Robustness 
Robustness of the method was studied by variation in temperature and wavelength by a 2 % 
change while other chromatographic conditions are kept constant. When wavelength changed by 
278 ± 2 nm no variation in peak retention time compared with the retention time of harpagoside 
peak at 278 nm which eluted at 3.6 min. Moreover, the results demonstrate that during 
temperature variance conditions, the retention time of the peak was slightly affected and shifted 
to 3.7 min with low % RSD and it was in accordance with that of actual harpagoside peak at 278 
nm which eluted at 3.6 min. The results are indicated in table 4.4. 
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         Table 4-4: method robustness  
Parameter 
Retention time 
(min) Mean, n = 
3 
                         % RSD 
Temperature (25 ± 2 
o
C) 
23 3.720 0.282 
27 3.779 0.687 
Wavelength  (278 ± 2 nm) 
276 3.720 1.023 
280 3.687 1.351 
 
Percentages RSD of peak areas were evaluated and all changes showed % RSD of less than 2 % 
(Venhatesh et al., 2010). Hence the analytical method would be concluded as robust. 
 
8. System suitability 
System suitability parameters were analyzed to check the system performance consistency and 
the resulted values are tabulated in table 4.5. 
  
                  Table 4-4: System suitability  
Parameter Average, n=3 Criteria 
Theoretical Plates 5821.667±3.90 ˃ 2000 
Tailing Factor 1.137±3.16 ˂ 2 
Peak Purity 8.976667±1.20 ˃ 0.98 
RT (min) 3.865333±1.17 Not applicable 
 
Theoretical plates indicates column efficiency with values more than 2000 reflecting   good 
separation of peaks. The harpagoside peak gave a value of 5821. Tailing factors for most peaks 
were ˂ 2, with a value of 1.137 indicating a perfectly symmetrical peak. Here, the peak purity 
was 8.97, which is in the system required suitability range (> 0.98). There was no interference or 
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co-eluting along with harpagoside at this retention time. All system suitability parameters met 
the acceptance criteria as shown in table 4.5 (Shabir, 2003).  
 
4.3   Quantitative determination of harpagoside constituent in plant extract 
The harpagoside yield in the crude H. procumbens extract was 2.6 %. This result was in line with 
the range reported in other studies (1.355 %; Poukens-Renwart et al., 1996, 1.62 %; Karioti et 
al., 2011 and 2.35 %; Boje et al., 2003). According to the standard set by the European and 
British Pharmacopoeias, the harpagoside content is required to be at least 1.2 % (dried drug) 
(Mncwangi et al., 2014). Hence the harpagoside content in the prepared H. procumbens extract 
was suitable to formulate the plant extract.  
 
4.4   Lipid vesicles preparation and characterization 
Lipid vesicles were successfully prepared with the thin film hydration method. Figure 4.13 is a 
photomicrograph of lipid vesicles captured under a microscope confirms the formation of the 
phospholipid vesicles on hydration of thin lipid film formed by the rotary evaporator. 
 
 
Figure 4-13 : Microscopic images of lipid vesicles. 
 
4.5    Preliminary study for determination of nano lipid vesicles formulation parameters 
Preliminary studies were conducted to ensure lipid vesicles formation and plant extract 
encapsulation in the vesicles. This included the selection of the phospholipid, method for size 
reduction, vesicles disruption and sonication time required for vesicle disruption. These 
methodical parameters were determined before the statistical response surface methodology 
(RSM) optimization of nano lipid vesicles was implemented.  
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4.5.1    Investigating the effect of lipid type on percentage encapsulation efficiency 
Soy L-a-PC and lecithin were utilized in the formulation as the lipid phase. From the results, the 
type of lipid used for the preparation of lipid vesicles appeared to affect the incorporation of the 
drug as differences in percentage encapsulation efficiency values were observed. High 
percentage encapsulation efficiency values were obtained when PC was utilized in the 
formulation as the lipid component and low values were obtained when Lecithin was utilized as 
represented in figure 4.14. 
 
Figure 4-14 : Histogram illustrating lipid type on percentage encapsulation efficiency. 
 
The lower percentage encapsulation efficiency demonstrated by lecithin may be due to the 
presence of other components like phospholipids, glycolipids and complex carbohydrates such as 
sucrose, raffinose and stachyose (van Nieuwenhuyzen et al., 2008). It could be that some of 
these impurities formed micelles rather than bilayer-lipid formations or interfered with the plant 
extract resulting in a decrease in % encapsulation efficiency. Imura et al. demonstrated high 
percentage encapsulation efficiency of liposome made from Lecinol S-10EX. This contains 95 % 
PC with low % encapsulation efficiency while liposome made from Lecinol S-10 contains 32 % 
PC. Based on these preliminary experiments PC was selected to formulate the lipid vesicle 
formulations due to its higher percentage encapsulation efficiency (Imura et al., 2003).  
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4.5.2   Investigating the optimal sonication time for vesicle disruption  
The optimal sonication time for the disruption of lipid vesicles was investigated. Prepared lipid 
vesicles were disrupted via sonication for different time periods. With increase in sonication time 
more harpagoside was released. The release at 3-5 min was similar as depicted in figure 4.15. 
 
Figure 4-15 : Sonication time for disrupt of lipid vesicles to release maximum amount 
of  loaded drug.  
 
There was an increase in the release of harpagoside between 1 and 3 min but increasing the 
sonication time from 3 to 5 min did not cause any further appreciable increase.  Sonication time 
of 3 min was selected to disrupt the prepared lipid vesicles. In addition, although the 5 min time 
interval resulted in a slightly higher breakdown of vesicles, the 3 min interval was selected due a 
decreased possibility of ethanol loss due to heat generated evaporation with increased sonication 
time. 
 
4.5.3   Investigating the influence of the lipid vesicle size reduction method on percentage 
encapsulation efficiency.  
Water bath sonication, probe sonication and extrusion method were applied to reduce lipid 
vesicle size. Each method displayed characteristic particle size and percentage encapsulation 
efficiency values. Encapsulation efficiency dropped from probe sonication ˃ extrusion ˃ water 
bath sonication. This is demonstrated in table 4.6. 
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Table 4-5: Influence of vesicles sizing down method on the percentage of encapsulation 
efficiency. 
 
Size reduction method 
Particle Size  
mean ± SD 
% EE  
mean± SD 
Probe sonication 103.66 ± 7.45 2.933 ± 1.3 
Water bath sonication 1066.36 ± 13.71 34.76 ± 5.67 
Extrusion 347.53 ± 17.15 15.95 ± 3.10 
         
The probe tip sonication method caused size reduction and low percentage encapsulation 
efficiency (2.9 %). The decrease may be due to the disruption of lipid vesicles as a result of 
subsequent heat build-up. Ding et al. (2009) reported that the decrease in encapsulation 
efficiency of ferrous glycinate liposomes with increasing of sonication strength, may be 
attributed to the high input of energy resulted in overheating ferrous glycinate leaking from the 
liposomes (Ding et al., 2009). Although, the energy was low because low intensity was utilized, 
it can be destructive to phospholipid molecules (Ong et al., 2016). Therefore, probe sonication 
was not the method of choice for size reduction.  
The water bath sonication method did not reflect reduction in particle size and the percentage 
encapsulation efficiency was high, as these were micro units sized particles. Work done by 
Perkins et al., (1993; Muppidi et al., (2012) shows that percentage encapsulation efficiency 
increase with particle size increases.  
The extrusion method exhibited appropriate particle size reduction with relatively lower 
percentage encapsulation efficiency compared to the water bath sonication method but higher 
than the probe sonication method. This might be as result of decrease in particle size of the lipid 
vesicles resulting in lower the drug loading (Ong et al., 2016).  Therefore a balance needs to be 
obtained between the size reduction required and the drug loading for practical application. Thus, 
the extrusion method was used as size reduction method for all further experiments. 
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4.5.4 Finding the appropriate plant extract ratio for appropriate percentage 
encapsulation efficiency 
The percentage encapsulation efficiency of prepared lipid vesicle batches with constant PC and 
cholesterol ratio and different plant extract ratio was 13.92 ± 1.007 at 2.5 mg/ml, 11.76 ± 0.46 at 
5 mg/ml and 15.04 ± 0.60 at 10 mg/ml as represented in the following figure 4.16. 
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Figure 4-16 : Effect of variation in plant extract content on the percentage 
encapsulation efficiency of  lipid vesicle formulations prepared with constant lipid 
phase content (plant extract: PC: cholesterol). 
 
When the plant extract concentration was increased from 2.5 to 5 %, there was no significant 
increase in percentage encapsulation efficiency, in contrast, when increased above 10 a % 
decrease in percentage encapsulation efficiency was observed. In the light of these results it was 
shown that using a fixed amount of lipid and different amounts of crude plant extract did not 
increase the percentage encapsulation efficiency significantly (p ˃ 0.05).  It might correspond to 
saturation of the lipid portion. These findings are similar to those reported previously by Singh et 
al., (2015).  In their study there was a slight increase in percentage encapsulation efficiency when 
the drug - lipid molar ratio changed from 1:2 to 2:2. Carafa et al. (2010) found that an increase in 
drug content from 6 to 60 mM, the drug loading decreased from 87 % to 79 % (Carafa et al., 
2010). Kan et al. (2010) reported that encapsulation efficiency was maintained even though the 
drug: phospholipid molar ratio was increased (Kan et al., 2010). Hence, in our study (2.5 mg/ml) 
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plant extract concentration was used in the optimization process with RSM. Beyond this ratio 
there was no change but a decrease in percentage encapsulation efficiency was observed.  
 
4.6   Response Surface Methodology (RSM) optimization process of nano lipid vesicles 
formulation 
 
4.6.1   Design of experiments 
Response surface methodology has been established as a convenient method for developing 
optimum processes with precise conditions and has also minimized the cost of production of 
many a process with efficient screening of process parameters (Francis et al., 2003).  
 
4.6.2   Generating experimental matrix 
For the optimization study, the output factor surface methodology (RSM) IV-optimal design was 
adopted to optimize experimental parameters and explore the effect of input factors. These were 
PC content; (X1), cholesterol content; (X2) and the type of the lipid vesicle; (X3).  The output 
factors viz. particle size; (Y1PS), polydispersity index; (Y2PDI) and percentage entrapment 
efficiency; (Y3%EE). The software generated design matrix with 17 experiments as refelected in 
table 4.7. These 17 experiments were performed as generated by the RSM matrix. The results of 
the output factors as per expermental runs were populated in table 4.7 as respone 1, 2 and 3. 
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Table 4 -6: Experimental matrix of RSM optimal design. 
 
  
4.6.3   Lipid vesicle characterization of RSM generated experiments  
The generated design matrix consisted of 17 experiments with different composition varied for 
liposome and phytosomes formulations. Particle size, polydispersity index and percentage 
encapsulation efficiency were measured and the results are depicted in table 4.7. The size range 
obtained varied between 208 nm and 609 nm. The polydispersity index values of the 
formulations were between 0.18 and 0.593 revealing that the particle polydispersity index was 
homogeneous in some formulations and hererogeneous in some. The percentage encapsulation 
efficiency of the lipid vesicles formulations was calculated and within the range of 2 % - 31.25 
%. Phytosomes, prepared with the same formulation as the liposomes demonstrated lower 
particle size and higher percentage encapsulation efficiency compared with liposomes, this can 
be seen when experiment 1, 12, 14 (liposomes formulations) were compared to 11, 5, 4, 
(phytosomes formulations) respectively. The variation in output values is believed to be due to 
variation in formulation composition. The following figure 4.17 shows the particle size and 
polydispersity index curve of two randomly selected formulations from those proposed by RSM. 
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Formulation 1 
 
Formulation 17 
Figure 4-17 : illustration of particle size of two randomly selected formulations (formulation 1 and 17) 
of  according to RSM.  
 
4.6.4   Analysis of RSM data and evaluation of the fitted output factor surface models 
The experimentally obtained output factor values of 17 experiment were fitted to various models 
namely linear, 2FI (2 factor interaction), quadratic and cubic by using Design Expert software to 
determine the data suitability model. A suitable model was selected based on lack of fit p-value 
and R
2
 values. The different model fitting values are shown in table 4.8.   
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Table 4- 7: Estimation of regression model, fit summary of the output factors Y1PS, Y2PDI 
and  Y3%EE, respectively. 
Source 
Sequential  
p-value 
Adjusted 
 R-Squared 
Predicted  
R-Squared 
Adequate 
 precision 
 
Y1      
Linear 0.3317 0.0449 -0.3272 1.40  
2FI 0.9309 -0.1900 -1.2363 2.28  
Quadratic 0.0065 0.810 0.737 7.027 Suggested 
Cubic 0.2449 0.7787   Aliased 
Y2      
Linear 0.0945 0.2337 -0.0425 4.62  
2FI 0.2028 0.3588 0.3034 3.11  
Quadratic 0.047 0.5571 0.5178 5.710 Suggested 
Cubic 0.9875 -0.0241   Aliased 
Y3      
Linear 0.0001 0.7397 0.6234 12.556 Suggested 
2FI 0.4049 0.7438 0.3588 9.626  
Quadratic 0.1190 0.8119 0.4724 6.215  
Cubic 0.1263 0.9398   Aliased 
   
The value of correlation coefficient (R
2
) is also an indication of the appropriateness of the 
selected model. From the table, the predicted and adjusted R
2
 of all models are in reasonable 
agreement with the adjusted R
2
. They are within 0.20 of each other (Jaafarzadeh et al., 2016) and 
is an indication of appropriateness of the selected models which are quadratic for Y1PS and Y2PDI 
and linear for Y3%EE.  Adequate precision measures the signal to noise ratio and compares the 
range of the predicted values at the design points to the average prediction error (Mourabet et al., 
2014).  The ratio greater than 4 is desirable and indicates this model can be used to navigate the 
design space according to the software. In this study, the ratio is found to be 7.02 for particle 
size, 5.71 for polydispersity index and 12.55 for percentage encapsulation efficiency. This 
indicates the adequateness and the reliability of the experiment data and this model can be used 
to navigate the design space. 
The statistical validity of the selected models was further established by ANOVA. The 
insignificant coefficients were eliminated after examining the coefficients, and the models were 
finally refined. Results of the ANOVA for all model selected for Y1PS, Y2PDI and Y3%EE are 
summarized in table 4.9, 4.10 and 4.11, respectively. 
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Table 4-8: Statistical parameters obtained from the ANOVA for the selected regression  model of    Y1PS 
generated from RSM software. 
 
   
Table 4-9 : Statistical parameters obtained from the ANOVA for the selected regression model for Y2PDI 
generated from RSM software. 
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Table 4.11: Statistical parameters obtained from the ANOVA for the selected regression model for      
Y3%EE generated from RSM software. 
 
 
 
ANOVA analysis was performed to choose a significant model and insignificant lack of fit for 
each output factor depends on p value. From the ANOVA analysis it is observed that models 
chosen for output factors (Y1PS, Y2PDI and Y3%EE had) had p value 0.006, 0.047 and 0.0001 
respectively. The very small probability values of the selected model of each output factor 
reflected that the model was significant for data set (p < 0.05). Moreover, the selected model had 
an insignificant (p value > 0.05) lack of fit p value = 0.303, 0.987 and 0.097, respectively. That 
confirms the adequacy of the model fit and demonstrated that the models were valid for the 
present work. A significant lack of fit (p < 0.05) is an undesirable property (according RSM) 
because it suggests that the model does not fit the data well and hence should not be used for 
further predictions.  
A normal probability plot indicates whether the residuals follow a normal distribution. The 
residual and corresponding normal probability plots of actual and predicted values for Y1PS, 
Y2PDI and Y3%EE are demonstrated in figure 4.18.1, 4.18.2 and 4.18.3, respectively . 
Residual plots indicate errors in the model are normally distributed with respect to run order as 
the data points on the plot lie close to a straight line. The normal probability plot of residuals for 
output factor Y2 PDI demonstrated all the points are close to the straight line except for two points 
which illustrate significance of those terms interactions (as per software). 
http://etd.uwc.ac.za/
 
 
83 
 
  
                        (a)                                                                          (b) 
Figure 4-18-1 : Normal plot of residuals (a), normal probability plot of actual and predicted values (b) 
of  particle size (Y1PS). 
 
  
(a)                                                         (b) 
Figure 4-18-2 : Normal plot of residuals (a), normal probability plot of actual and predicted values (b) 
of polydispersity index (Y2PDI). 
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(a)                                                                       (b) 
Figure 4-18-3 :  Normal plot of residuals (a), normal probability plot of actual and predicted values (b) 
of percentage encapsulation efficiency (Y3%EE). 
 
For normal probability plot of actual and predicted values the actual results are shown on the 
vertical axis while the results predicted by the RSM model are along the horizontal axis. This 
will be the same for all of the following normal probability plots. The majority of points cluster 
around the diagonal line indicated a satisfactory correlation between the observed and predicted 
output factor values because minor departures from normality are acceptable (Alshamrani, 2017) 
and further shows a good fit of the model.  
 
4.6.5   Effect of input factor on output factor Y1PS (particle size)  
One of the most important parameters, which need to be monitored during lipid vesicles 
preparation, is the vesicle size and the polydispersity index. It is evident that the particle size and 
polydispersity index of the liposomes determine their in vitro or in vivo performance 
(Ghanbarzadeh et al., 2013). The particle sizes of lipid vesicles were in a range of 382.6 to 608.7 
nm for liposomes and for phytosomes in a range of 207.8 to 596.4 nm.  The particle size values 
of liposomes and phytosomes formulation generated by RSM are represented in the following 
table 4.12. 
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Table 4.12: Particle size of liposomes and phytosomes formulation (extracted from table 4.7) 
F. code 
Factor 1; 
PC % 
Factor 2; 
Chol% 
Factor 3; 
Vesicle type 
Response 1 
Particle size (nm) 
1 80 40 liposome 608.7 
2 45 40 phytosome 531.1 
3 80 22.5 phytosome 596.4 
4 10 5 phytosome 328 
5 10 40 phytosome 434.6 
6 80 5 liposome 546 
7 80 5 phytosome 527.8 
8 45 5 phytosome 587.5 
9 45 22.5 liposome 474.8 
10 10 22.5 phytosome 207.8 
11 80 40 phytosome 587.1 
12 10 40 liposome 437.5 
13 45 22.5 liposome 446.9 
14 10 5 liposome 491.7 
15 45 22.5 liposome 382.6 
16 45 5 liposome 496.9 
17 45 22.5 liposome 511.5 
 
The table shows that particle size (Y1PS) increased as PC and cholesterol quantities increase for 
liposome and phytosomes. This is due to phospholipids constituting the lipid vesicle membrane 
and PC concentration directly affects the particle size of the lipid vesicle (Ma et al., 2012), 
cholesterol also increases the thickness of phospholipid bilayer (Hung et al., 2007). This vesicle 
size increase was demonstrated by Song et al, (2008) with silybin-phospholipid complex. Similar 
observations were reported with ketotifen liposomes and quercetin liposomes with increasing PC 
and cholesterol respectively (Yas, 2014 and Rasaie et al., 2014). This is also confirmed from the 
resulted RSM regression model: 
Y1PS     = 396.00 +36.13 A +0.86 B - 44.65 C -111.35 A
2 +
175.41 B
2
.                                         Eq 14.                                   
From the equation it can be seen that the input factor PC content (A) and cholesterol content (B) 
had positive (+) values. They had positive effects on particle size i.e. an increase in their 
concentrations led to an increased particle size. This can be seen for PC effect when compare the 
experiments (1, 12 and 6, 14) for liposomes and (3, 10 and 2, 11) for phytosomes with constant 
plant extract and cholesterol content and different PC content, and for cholesterol effect can be 
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seen when compare the experiments (16-17and 4,5) for liposomes and phytosomes ,respectively 
in table 4.8. 
For a better explanation of the input factors and their interactive effects on the particle size, 
three-dimensional (3D) surface plots were generated using equation14.These are represented in 
figure 4.19.1. Flatness of surface suggested that interaction between factors was weak (Zhao et 
al., 2014). The plot shows that the particle size increases as PC content increases and does not 
change as much as cholesterol content changes. 
 
 
Figure 4-19-1: Three-dimensional (3D) surface plot showing the effect of P 
and  cholesterol content on particle size; Y1PS.‎ 
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4.6.6  Effect of input factors on output factor Y2PDI (polydispersity index)  
The polydispersity index of liposomes and phytosomes formulations generated by RSM was 
evauated and tabulated in the following table (table 4.13). 
 
Table 4.13: Polydispersity index of liposomes and phytosomes formulation (extracted from 
table 4.7). 
 
F. code 
Factor 1; 
PC % 
Factor 2; 
Chol % 
Factor 3; 
Vesicle type 
Response 2 
PDI 
1 80 40 liposome 0.361 
2 45 40 phytosome 0.547 
3 80 22.5 phytosome 0..369 
4 10 5 phytosome 0.272 
5 10 40 phytosome 0.379 
6 80 5 liposome 0.18 
7 80 5 phytosome 0.182 
8 45 5 phytosome 0.375 
9 45 22.5 liposome 0.353 
10 10 22.5 phytosome 0.288 
11 80 40 phytosome 0.479 
12 10 40 liposome 0.528 
13 45 22.5 liposome 0.414 
14 10 5 liposome 0.558 
15 45 22.5 liposome 0.268 
16 45 5 liposome 0.418 
17 45 22.5 liposome 0.593 
 
 
The design matrix (table 4.9) shows that PDI decreases as PC concentration increases, indicating 
complete complexion. Reduction in PDI of phytosomes containing diosmin was similarly 
reported by Freag et al., (2013). Generally, PDI was higher (broad polydispersity index) when 
the vesicles type were liposomes. Moreover, in equation 15, increasing the PC concentration 
displayed a minus (-) value, resulting in a decrease in the polydispersity index, which is 
desirable. 
 
Y2PDI     = 0.37 -0.077 A +0.072 B -0.032 C +0.050 AB +0.059 AC +0.024 BC -0.11A
2 +
0.10 B
2
.   Eq 15 
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This can be seen when compare liposomes formulations for example (14, 16) and phytosomes 
formulations (7, 8) with constant plant extract and cholesterol quantity and different PC quantity 
and in case of cholesterol the equation represent the cholesterol had negative effect as it had 
minus value, which means increase its concentration leads to increase in PDI, this can be seen 
when compare experiments (1, 6) in case liposomes and (3, 7, 11 and 2, 8- 4, 5) in case of 
phytosomes.  
 
 The relationship between the input and output factors was further elucidated using surface plots 
in figure 4.19.2. Which represent that polydispersity index for different formulations decrease 
with increasing in PC content. 
 
 
 
Figure 4-19-2 : Three-dimensional (3D) surface plot showing the effect of PC 
and  cholesterol content on polydispersity index (Y2PDI). 
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4.6.7  Effect of input factors on percentage encapsulation efficiency Y3%EE (percentage 
encapsulation efficiency) 
The percentage encapsulation efficiency of liposomes and phytosomes formulation generated by 
RSM are evaluated and represented in the following table 4.14. 
Table 4.14: Percentage encapsulation efficiency of liposomes and phytosomes formulations 
(extracted from table 4.7). 
 
F. code 
Factor 1; 
PC % 
Factor 2; 
Chol % 
Factor 3; 
Vesicle type 
Response 3 
%EE 
1 80 40 liposome 14.6 
2 45 40 phytosome 19.51 
3 80 22.5 phytosome 30.95 
4 10 5 phytosome 9.52 
5 10 40 phytosome 15.38 
6 80 5 liposome 21.2 
7 80 5 phytosome 27.02 
8 45 5 phytosome 24.4 
9 45 22.5 liposome 17.7 
10 10 22.5 phytosome 2.6 
11 80 40 phytosome 31.25 
12 10 40 liposome 2.38 
13 45 22.5 liposome 12.5 
14 10 5 liposome 2 
15 45 22.5 liposome 15.83 
16 45 5 liposome 23.4 
17 45 22.5 liposome 13.95 
 
The design matrix shows a higher percentage encapsulation efficiency when lipid vesicles type  
was phytosomes and the percentage encapsulation efficiency increased as PC was increased and 
this can be seen when compare between experiment 1 and 12 for liposomes, and 4 and 7 in the 
case of phytosomes. This increase can be attributed to the vesicles having sufficient PC 
molecules to self-assemble into phytosomes, and as a result more plant extract molecules become 
favourably entrapped in the phytosomes rather than in bulk solution (Abdelkader et al., 2016). 
Further, from model regression equation 16, one observes that the PC concentration and 
cholesterol concentration have a positive effect, as they had a positive (+) value, which reflected 
in an increase in their concentrations lead to increase percentage encapsulation efficiency of lipid 
vesicles. 
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Y3% EE        = 16.81 +9.31 A +1.73 B +3.27 C.                                                                      Eq 16.                                                                                                             
Ghanbarzadeh et al. (2014) reported that increase in PC led to increasing encapsulation 
efficiency of naproxen nano liposomes. Similarly, Ma et al (2012) reported that encapsulation 
efficiency of lactoferrin nano-liposomes increased as PC increased.  
As for cholesterol effect, its high ratio led to higher percentage encapsulation efficiency as 
observed in (3, 7 and 4, 5), although its effect was negative in some experiments viz. (4, 10) 
which may be due to it critical level, hence, at higher concentrations cholesterol can form crystal 
habits (Mohammed et al., 2004) that may start to disrupt the bilayer structure, leading to the loss 
of drug entrapment levels. Ding et al. (2009) and Agarwal et al. (2001) reported that decreasing 
entrapment efficiency with further increasing cholesterol ratio beyond a certain limit. Figure 
4.19.3 indicates the surface plot of the percentage encapsulation efficiency along with cholesterol 
and PC content. This shows that the high PC content and the high percentage encapsulation 
efficiency. The plot demonstrates that PC had more effect than cholesterol.   
 
 
Figure 4-19-3: Three-dimensional (3D) surface plot showing the effect of PC 
and  cholesterol content on percentage encapsulation efficiency.  
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4.6.8  Formulation optimization using desirability function 
After the establishment and analysis of appropriate models for individual output factors, the 
simultaneous optimization of multiple output factors was carried out using Design Expert 
software to find a combination of factor levels that simultaneously satisfy the requirements 
placed on each of the output factors and input factors. 
In this step, the optimal conditions such as minimum particles size, polydispersity index as well 
as maximum percentage encapsulation efficiency was determined by using the desirability 
function approach. The optimization step generated 6 checkpoint scenarios. The highest with a 
desirability factor of 0.774 was selected as the most desirable optimized formulation. The 
desirability ramp in figure 4.20 represents the various input and output parameters generated for 
this formulation which consists of PC concentration 80 %, cholesterol concentration 5 % and the 
type of lipid vesicle prepared phytosome with predicted small particle size range 531.29 nm, 
small polydispersity index range 0.230, and percentage encapsulation efficiency 31.12 %.  
 
 
Figure 4-20 : Desirability ramp for the optimization process. 
 
4.6.9  Verification of optimized condition 
The optimized formulation values were further validated by carrying out the experiment at 4 
replicates and values of output were determined experimentally. The average values after 
experimentation were compared to the model predicted values which are 531.29 nm particle size, 
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0.230 polydispersity index and percentage encapsulation efficiency 31.12 %. Figure 4.21 
shows particle size, polydispersity index and percentage encapsulation efficiency of this 
comparison. The verified particle size was 509.97 ± 29.9 nm, polydispersity index was 0.213 ± 
0.03 and percentage encapsulation efficiency was 28.60 ± 2.4 %.  The average percent errors are 
found to be -9.82 ± 6.7 % for percentage encapsulation efficiency, - 4.01 ± 4.8 % for particle size 
and -7.06 ± 13.9 % for polydispersity index. These percentage error values   are sufficiently low 
to confirm the high predictive power of the RSM (Bassi et al., 2015). The figure indicates good 
agreements between the experimental and predicted values.  
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Figure 4-21 : Observed values of optimized formula (particle size, polydispersity index and 
%  encapsulation efficiency) in comparison with proposed optimized formulation of  RSM. 
 
4.7 Characteristics of selected optimised formulation 
Based on the above findings, a phytosome formulation containing 80 % PC and 5 % cholesterol 
was selected as the final optimized formulation. 
 
4.7.1 Particle size and polydispersity index 
Figure 4.22 demonstrates the 4 replicates of the optimised formulation with a mean particle 
diameter of 509.97 ± 29.9 nm indicating LUV as the lipid vesicle type because the particle size 
was more than 100 nm (Pattni et al., 2015). It also has a polydispersity index of 0.21 ± 0.036 
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which indicates narrow polydispersity index and homogeneity of lipid vesicles which is desirable 
in the manufacture of phytosomes (de Sousa et al., 2013).   
 
 
Figure 4-22 : Particle size for final optimized phytosomes formulation. 
 
4.7.2 Zeta Potential Analysis 
The optimized phytosome formulation carries a low negative charge (−8.3 ± 0.72 mV). These 
findings are in agreement with the finding of Freag et al. who reported the lyophilized diosmin 
phytosomes manufactured from soya PC carried low negative charge (−6 mV) (Freag et al., 
2013). The low optimized phytosomes formulation zeta potential value indicates stability 
possible problems with stability (Thassu et al., 2012).  
The mean of zeta potential values of all the liposomes and phytosomes formulations proposed by 
RSM were also investigated using the Zetasizer, although it was not one of the dependant 
factors. The results are displayed in table 4.15. 
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                 Table 4 -15: Zeta potential results of proposed formulation by RSM 
F. code 
Factor 1; 
PC % 
Factor 2; 
Chol% 
Factor 3; 
Vesicle type 
Zeta potential (mv) 
(mean±sd, n=3) 
1 80 40 liposome -5.14  
2 45 40 phytosome -3.26  
3 80 22.5 phytosome -4.55  
4 10 5 phytosome -0.19  
5 10 40 phytosome -0.54  
6 80 5 liposome -6.64  
7 80 5 phytosome -6.78  
8 45 5 phytosome -4.47  
9 45 22.5 liposome -2.59  
10 10 22.5 phytosome -1.08  
11 80 40 phytosome -7.73  
12 10 40 liposome -0.26  
13 45 22.5 liposome -3.27  
14 10 5 liposome -0.51  
15 45 22.5 liposome -5.26  
16 45 5 liposome -4.18  
17 45 22.5 liposome -2.89  
 
As can be observed from the table that all vesicles displayed a negative surface charge (-7.7 to - 
0.2 mV) due to the presence of the phosphate group of PC at neutral pH (Allam et al., 2015).  
Zeta potential is an index commonly used to assess the stability of the lipid vesicles. The zeta 
potential indicates the degree of repulsion between, similarly charged particles in dispersion. 
Zeta potential values beyond +30 mV or below -30 mV are generally considered to be an 
indication of stability through strong repulsion forces among particles to prevent aggregation 
(Haidar et al., 2008). When the potential is low it leads to attrition of particles and the dispersion 
will break and flocculate (De et al., 2012).  
These results obtained for the zeta potential was out of the recommended charge range, therefore 
the need arose to search for a way to increase the surface charge in an attempt to increase the 
stability of lipid vesicles. Stearic acid has been used as charge inducer (Sudhakar et al., 2014). 
Stearic acid, a charge inducer component was included to the optimized H. procumbens 
phytosomes formulation to improve the zeta potential. The formulation was tested for particle 
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size, polydispersity index and zeta potential. The results were compared with the optimized 
formulation without stearic acid. The results are represented in figure 4.23.  
 
Figure 4-23 : Incorporation of stearic acid as charge inducer significantly (p ˂ 
0.05)  enhances the zeta potential of the phytosome optimized formulation. 
 
The zeta potential was significantly (p ˂ 0.05) improved when stearic acid was added to the 
optimized formulation. Results revealed that zeta potential of the empty phytosomes was -1.34 ± 
1.14 mV and the loaded optimized phytosomes formulation was −8.3 ± 0.72 mV, and when the 
stearic acid was included the zeta potential became –30.6 ± 0.80 mV (figure 4.24) due to the 
surface charge imparting nature of stearic acid (Sudhakar et al., 214). This may serve as a partial 
indicator of physical stability to ensure creation of a high-energy barrier against rupture or 
coalescence of the formed globules. 
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Figure 4-24: Zeta potential of empty phytosomes (blue peak), loaded H. procumbens phytosomes 
(red peak), and loaded H. procumbens phytosomes including stearic acid (green peak). 
 
There was small change in phytosomes particle size changing from 525.5 ± 21.12 to 512.3 ± 
38.17 and the encapsulation efficiency changed from 28.01 ± 1.51 to 27.58 ± 2.75, which is 
considered statistical insignificant. Similarly reported by Marsanasco et al. they demonstrated 
that the addition of stearic acid to liposomes produced slight changes in particle size and 
liposome encapsulation efficiency when working with vitamin loaded liposomes (Marsanasco et 
al., 2011). The all next characterization and investigation studies were performed on optimized 
phytosomes formulation included stearic acid. 
 
4.7.3 Scanning Electron Microscopy (SEM)  
Morphological characteristics were observed by SEM. The photomicrography provided evidence 
of vesicle formation and also showed the shape. Their morphology evaluation demonstrated that 
phytosomes were discrete and spherically shaped as depicted in figure 4.25. 
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Figure 4-25‎: Representive SEM micrograph of optimized H. procumbens phytosomes at two 
different ‎magnifications.‎ 
 
4.7.4  Solubility 
Figure 4.26 indicates the measured solubility of H. procumbens plant extract and phospholipid 
complex (phytosomes) in water and n-octanol, respectively. The plant extract had a low lipid 
solubility of 0.002829 ± 0.0005 mg/ml, and a relatively higher aqueous solubility of 0.559008 ± 
0.002 mg/ml, indicating a hydrophilic nature. The prepared H. procumbens phytosomes 
demonstrated an increase of 0.05297 ± 0.001268 mg/ml in the lipid solubility compared to the 
plant extract. This form could improve the passage of the plant extract across the lipid-rich cell 
membranes of the intestine wall (lipid diffusion) and increase its absorption.  
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Figure 4-26 : Represents the apparent solubility of H. procumbens extract and phytosomes in 
water  and n-octanol. 
 
The overall amphiphilic nature of the prepared H. procumbens phytosomes can be attributed as 
the main reason for this observed increase in lipid solubility. Vankudri et al., (2016) reported that 
rutin-phospholipid complex increased the solubility of rutin in n-octanol more than in water. The 
results for H. procumbens phytosomes assumes  absorption and therefore bioavailability because 
it possesses both hydrophilic and lipophilic qualities which offers better dissolution in the GI 
fluid and also better absorption through the lipophilic membrane or tissue system. 
 
4.7.5 FTIR study 
To detect the possible interaction between the plant extract and PC in the phospholipid complex 
FTIR was completed. The IR spectrum figure 4.27 of the empty phytosomes showed 
characteristic absorption bands at 3373.52 cm
-1 
for a hydroxyl (-OH) group and C–H stretching 
bands of a fatty acid chain at 2924.43 and 2,854.18 cm
-1
, carbonyl stretching band at 1,734.02 
cm
-1  
in the fatty acid ester, at 1466.34 cm
-1
 for C-H bending, P=O stretching band at 1,238.67 
cm
-1 
,P–O–C stretching band at 1,087.51 cm-1 and choline N-(CH3)3  stretching at 969.49 cm-1. 
These results of FTIR are well supported by the previous work by Zhang et al., (2016) with non-
considerable shifting. Their study indicated that PC demonstrated characteristic peaks at 3384.1 
cm
-1
 (Hydroxyl stretching); 2925.2 and 2854.2 cm
-1 
(C-H stretching of long fatty acid chain); 
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1736.4 cm
-1 
(carbonyl stretching of the fatty acid ester);1466.1 cm
-1 
 (C-H bending); 1242.9 cm
-
1 
(P = O stretching band); 1090.0 cm
-1
 (P-O-C stretching) and 968.4 cm
-1
 (N
+
(CH3)3 stretching.  
The H. procumbens extract exhibited a characteristic band at 3293.83 cm
-1  
for a hydroxyl (-OH) 
group and at 2926.43 cm
-1 
(for C-H stretching) and 1627.82 cm
-1
. This indicates the presence of a 
carbonyl (C=O) group and 1346.36 cm
-1  
for (C-H bending) and 991.68 for (C-O group). 
The FT-IR spectrum of the complex (phytosomes), showed significant changes. The absorption 
peak of hydroxyl (O–H) stretching of empty phytosomes shifted to lower wave number at 
3352.62 cm
-1
 in complex. This could indicate the interaction of plant extract to polar end of the 
PC through formation of strong hydrogen bonding between hydroxyl groups of phospholipid and 
extract phytoconstituents in phytosomes (Vankudri et al., 2016; Singh et al., 2013). Shifting of 
the P=O absorption band of PC molecule to lower frequency (1235.92 cm-1)  further indicates  
the sensitivity of these vibrations to the formation of H-bonds (Süleymanoglu, 2009)
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Figure 4-27 : FTIR spectra of (A) empty phytosomes, (B) H. procumbens plant extract and (C)  H. procumbens loaded phytosomes. 
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These results are in good agreement with those of (Dhase et al., 2015) who reported shifting of 
the hydroxyl group (OH) to a lower frequency in the spectra of phytosomes (3625cm
-1
 to 
3560cm
-1
). They indicated the formation of strong hydrogen bonding between the hydroxyl 
group of the phospholipid and leaves of Aegle marmelos (Bael) extract phytoconstituents during 
complex formation.  
 
4.7.6    Stability in simulated gastric fluid (SGF) pH 1.2.  
The effect of gastric pH on H. procumbens phytosomes integrity was evaluated to mimic the 
stability range of these lipid vesicles after oral administration. The physicochemical 
characteristics of the phytosomes formulation were investigated: 
 
1) Phytosomes particle size    
The results of the in vitro stability study investigation of the H. procumbens loaded phytosomes 
and the control (empty phytosomes) in SGF are illustrated in figure 4.28.1. This shows an 
increase in particle size of loaded phytosome and the control after 2 hours incubation with the 
SGF (pH 1.2). This increase continued  significantly (p ˂ 0.05) after 4 hours from 481.75 ± 7.36 
nm to 570.95 ± 4.03 nm in case of loaded phytosomes and increased also  statistically 
significantly (p ˂ 0.05) from 473.65 ± 47.44 to 522.95 ± 10.53 for empty phytosomes. 
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Figure 4-28-1 : Particle size of empty and loaded H.procumbens phytosomes against simulated 
gastric fluid ‎ (SGF) 37 oC for 4 hours (mean ±sd, n =2). 
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The possible explanation for size increase is that it may be due to vesicle aggregation.  
Channarong et al., 2011 reported an increase in polyplex liposomes particle size in low pH 
medium. Similarly, Ramana et al., 2010 reported an increase in the size of nevirapine liposomes 
in acidic media. This change in particle size is an indication of the instability of phytosomes in 
acidic medium (gastric environment). 
 
2) Phytosomes polydispersity index (PDI)   
The results obtained from PDI analysis of empty and loaded phytosomes can be seen in figure 
4.28.2, The PDI changed from the initial value of 0.27 ± 0.03 to 0.38 ± 0.01 after 4 hours for 
empty phytosomes and for loaded H. procumbens phytosomes, the PDI changed from 0.25 ± 
0.01 to 0.45 ± 0.12. This is a further indication of instability of phytosomes in acidic medium.  
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Figure 4-28-2: Polydispersity index of empty and loaded H.procumbens phytosomes against 
simulated gastric fluid ‎ (SGF) at 37 oC for 4  hours (mean±sd, n=2). 
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3) Phytosomes zeta potential 
The results obtained from the zeta potential analysis for empty and loaded phytosomes are shown 
in figure 4.28.3. 
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Figure 4-28-3: Zeta potential of empty and loaded H. procumbens phytosomes against 
simulated gastric fluid simulated  gastric fluid at 37 oC for 4 hours (mean±sd, n=2). 
 
The results reveals a statistically significant (p ˂ 0.05) decrease in the initial zeta potential (- 
23.85 ± 2.05 mV) of the empty phytosomes at 4 hours (-18.35 ± 2.19 mV). For loaded H. 
procumbens phytosomes the zeta potential decreased (statistically significant) from (-33.05 ± 
1.20 mV) to (-13.85 ± 1.48 mV). This decrease in charge is possibly due to neutralization and 
ionization of phosphate polar head group of the PC in the acidic medium (Channarong et al., 
2011). The zeta potential decreasing was further indication phytosome instability in gastric 
medium. 
 
4) H. procumbens phytosomes release study in SGF 
A burst release in the first hour was observed for the H. procumbens phytosomes in SGF, 
followed by a steady release for 4 hours. The phytosomes demonstrated release of 40.44 ± 1.55 
% in SGF after 4 hours (figure 4.28.4).  
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Figure 4-28-4 : Harpagoside release from H. procumbens phytosomes in simulated 
gastric fluid (SGF) (mean±sd, n=3). 
 
The release of the contents from these phytosomes could occur when the excess hydrogen ions 
present in the SGF, diffuse in the inner space of the H. procumbens phytosomes. It competes 
with plant extract to combine with the anionic phosphate groups of PC and disturb the weak 
interaction balance of the phytosomes, leading to the plant extract release from the H. 
procumbens phytosomes (Yu et al., 2016). The same trend was reported by Zhang et al., (2014) 
who found 55 % of insulin released in SGF from liposomes made from soybean PC. This is the 
same phospholipid type used in our study. Release of plant extract from the phytosomes in 
gastric medium is not desirable because it indicates phytosomes instability in this this medium. 
To protect the plant extract from the gastric environment and enhance its absorption in the 
intestinal region, the phytosomes should be keeping intact in the gastric environment. We 
therefore suggest that coating the phytosome with the alginate polymer will prevent it from 
releasing the plant extract early in the acidic (gastric) environment.  
 
4.8 Phytosome -  alginate system 
 
4.8.1 Preparation of the alginate coated H. procumbens phytosomes  
Alginate coated- H. procumbens phytosomes were successfully prepared by ionotropic gelation 
technique by using sodium alginate and calcium chloride as a cross-linking agent. The colour of 
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alginate coated - H. procumbens phytosomes crosslinked with calcium chloride was relatively 
opaque white and changed to yellowish brown after drying as indicated in figure 4. 29. 
 
 
Figure 4-29 : dry and freshly prepared alginate coated H. procumbens phytosomes. 
 
4.8.2 Process variables and process optimization 
Different variables, i.e. concentrations of sodium alginate and of calcium chloride were 
investigated for their effect on particle size, percentage encapsulation efficiency and 
disintegration time and release behaviour.  
 
4.9 Characterization of alginate coated H. procumbens phytosomes 
 
4.9.1 Particle size 
Bead size was measured using a light microscope and found to be within a narrow size range of 
1.19 ± 0.06 mm and 2.24 ± 0.07 mm. The mean particle size differed between the formulations 
with varying concentrations of alginate and calcium chloride as represented in figure 4.30. There 
was an increase in the average diameter of particles with an increase in the concentration of 
sodium alginate polymer. No statistical difference between empty and loaded beads size was 
detected.   
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Figure 4-30 :  Alginate coated H. procumbens phytosomes particle size as a function of different 
alginate and  calcium chloride concentrations (mean±sd, n=3). 
 
It is worth noting that sodium alginate polymer content had significant (p ˂ 0.05) effect on beads 
size. Larger beads were obtained when concentration of sodium alginate was increased. This was 
probably due to larger drops dispersed from the syringe during the bead formation process as a 
result of increased viscosity of the alginate solution. Similarly, it has been reported that large 
tinidazole alginate beads were prepared with alginate concentration above 3% (Singhal et al., 
2010). Studies by (Patil et al., 2014; Das et al., 2007; Manjanna, 2009) further support this 
findings. It was also observed that at high sodium alginate concentration the beads maintained 
their form integrity whereas at lower concentrations the beads deformed and lost their shape after 
drying. The same trend was reported by Singh et al., (2012).  
 As depicted in the figure, the beads particle sizes decreased [not statistically significant (p ˃ 
0.05) when calcium chloride concentration was increased from 2 % (w/v) to 4 % (w/v). This 
decreased bead size is due to a high degre e of crosslinking causing shrinkage of the beads 
(Abdalla et al., 2015). This result was similar to studies performed by (El-Kamel et al., 2010; 
Nayak et al., 2011; Bansal et al., 2016). 
 
4.9.2 Percentage encapsulation efficiency of alginate coated H. procumbens phytosomes 
The alginate coated H. procumbens phytosomes percentage encapsulation efficiency of 1 %, 2 % 
and 4 % was investigated and the results represented in figure 4.31. The percentage 
encapsulation efficiency was between 12.80 ± 2.51 % and 57.79 ± 6.74 %.  
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Figure 4-31‎: Alginate coated H. procumbens phytosomes percentage entrapment 
efficiency at different alginate and  calcium chloride concentrations (mean±sd, n=3). 
 
The results indicate the higher the concentration of alginate and calcium chloride the higher the 
capacity of beads to hold the phytosomes. The highest being 57.79 % ± 6.74. The lower 
percentage encapsulation efficiency observed at lower alginate concentrations may be due to the 
phytosomes not encapsulated completely because of less available active calcium-binding sites 
in the polymeric chains and, consequently, a lower degree of cross-linking with the gelling agent 
leading to the formation of lower strength matrix structure (Thomas et al., 2011). The increase in 
percentage encapsulation efficiency at higher alginate concentration is attributed to the increase 
in viscosity at a higher concentration of sodium alginate due to the formation of a denser matrix 
structure (Patel et al., 2016). 
The percentage encapsulation efficiency increased significantly (P < 0.05) when calcium 
chloride concentration was increased from 2 % - 4 % w/v. The percentage encapsulation 
efficiency increase may be attributed to the greater availability of active calcium binding 
sites in the polymeric chains resulting in better cross-linking reactions and compactness of 
the formed insoluble dense matrices (Suruse, 2014). This is similar to results observed by Takka, 
(1999) for nicardipine calcium alginate beads and by Manjanna et al., (2013) for aceclofenac 
sodium microbeads. 
Higher percentage encapsulation efficiency depends on both the concentration of sodium alginat 
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and calcium chloride in the formulation. These findings are in agreement with (Vinod et al., 
2013) who reached the higher entrapment efficiency based on the concentration of sodium 
alginate and the ability of the calcium ions to crosslink with sodium alginate.  
 
4.9.3 Alginate coated H. procumbens phytosomes erosion and release study 
Short erosion and release study in PBS was performed to determine the time period for alginate 
coated H. procumbens phytosomes to disintegrate and release the phytosomes. The rate of 
release of the formulations was between 26.11 ± 2.42 and 4.14 % ± 2.37 as shown in figure 4.32. 
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Figure 4-32 : Erosion and release from alginate coated H.procumbens phytosomes at 
different sodium  ‎concentrations; (A) 2% calcium chloride (B) 4% calcium chloride as 
cross linking solution  (mean±sd, n=3). 
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Figure 4 shows that a decrease in polymer ratio, decreased the time for bead erosion. The 
presence of lower amounts of sodium alginate produces a highly porous matrix structure having 
low gel strength; this resulted in rapid diffusion of the drug from the matrix (Thomas et al., 
2011). Similar results were observed for trimetazidine alginate beads, the lower concentrations of 
sodium alginate led to faster trimetazidine release (Mandal et al., 2010). The results show no 
appreciable (p > 0.05) difference between the releases rates of the formulation with different 
calcium chloride concentrations (2 % and 4 %). These results are in agreement with Thomas et 
al. (2011) who reported that increasing the concentration of CaCl2 produced a non-significant 
effect on dissolution behaviour. 
In the case of formulations prepared with a high content of sodium alginate, the erosion time 
increased, alginate coated H. procumbens phytosomes expanded but did not erode in 2 hours. 
This is illustrated in figure 4.33. The decreased release of entrapped phytosomes is related to high 
crosslinking delaying alginate gel disintegration (Chowdhury et al., 2011). 
 
 
Figure 4-33 : Pictures of alginate coated H. procumbens phytosomes in PBS 7.4 at 
different sodium alginate  concentrations formulation and 4% CaCl2 during erosion 
study. 
 
Overall, considering the beads size, percentage encapsulation efficiency, erosion and release 
characteristics of alginate beads, it was found that optimum concentration of sodium alginate (2 
%), calcium chloride (4 %). This formulation was selected and subjected for further 
investigation.  
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4.9.4 Shape and surface assessment of selected alginate coated H. procumbens phytosomes 
The shape of visually dry and freshly prepared alginate coated H. procumbens phytosomes was 
examined. The dried alginate coated H. procumbens phytosomes were seen to be spherically 
shaped as demonstrated in figure 4.34.1. 
 
             
Figure 4-34-1: Spherical shape of dry and freshly prepared alginate coated H. procumbens 
phytosomes. 
 
Examination of the surface structure are depicted in figure 4.34.2 reveals small cracks on the surface 
probably caused by partial collapsing of the alginate polymer network during the dehydration process. 
 
 
Figure 4-34-2: SEM micrograph of surface microstructure of the dried alginate 
coated  H. procumbens phytosomes.   
 
4.9.5 Phytosomes- polymer compatibility study 
 H. procumbens phytosomes - alginate compatibility studies were done using a FTIR 
spectrometer. The spectra of sodium alginate powder, empty alginate beads and alginate coated H. 
procumbens phytosomes are represented in (Figure 4.35). 
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Figure 4-35: FTIR spectra of sodium alginate, empty alginate coated phytosomes, H. procumbens  phytosomes and alginate coated H. 
procumbens phytosomes
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Sodium alginate demonstrated a characteristic broad peak for – OH because alginate is a 
carbohydrate polymer, which has OH groups in their structure (Saleem et al., 2012), 
confirmed by the broad peak at 3246.77 cm
-1
. The two band peaks at 1594.73 cm
-1 
and 
1407.34 cm
-1 
were identified as the asymmetric and symmetric stretching vibrations of the C–
O bond of the COO group, respectively, and the peak at 1025.80 cm
-1 
indicates stretching 
vibrations of the C–O of the glucourinic unit. These peak bands were in line with the 
neglectable shift with the alginate bands findings of Mohandas et al., (2015) who represented 
three distinct peaks for alginate bandage (1,593 cm
−1
, 1,409 cm
−1 
and
 
1,026 
cm
−1
respectively).  
The empty alginate beads spectrum demonstrated broad and strong –OH bending occurred at 
3354.81and some distinct peaks such as carboxyl group demonstrated strong absorption 
bands at 1594.84 cm
-1
 and 1416.81 cm
-1
 due to carboxyl anions asymmetric and symmetric 
stretching vibrations. The stretching vibrations of the C–O of the glucourinic unit occurred at 
1027.92 cm
-1
.
 
 
In the spectra of empty alginate beads, the shift in the peaks of empty alginate beads vs. 
sodium alginate indicated the involvement of the COO group in the Ca
2+ 
mediated processes 
of alginate reticulation and egg-box-structure formation, and replacement of the Na+ in the 
uronic-acid residues by Ca
2+
  i.e. confirming crosslinking. This is in agreement with the study 
of ultra-high concentration calcium alginate beads, where the representative peaks at 1594 
and 409 shifted to 1593 and 1417, respectively (Voo et al., 2015) 
Alginate-coated H. procumbens phytosomes (loaded alginate beads) demonstrated almost the 
same peaks of empty alginate with no appreciable shift i.e. 3353.39 cm
-1,
 1598.09 cm
-1,
 
1417.26 cm
-1  
and 1031.47 cm
-1  
. Moreover, it demonstrated three peaks 2922.09 cm
-1,
 
2851.93 cm
-1  
 and 1236.09 cm
-1 
which correspond to
 
H. procumbens phytosomes as 
represented in the figure, which elucidates no significant chemical reaction occurred between 
H. procumbens phytosomes and alginate polymer, confirming compatibility of the polymer 
with the phytosomes and the phytosomes is present in unchanged form. 
The results indicate that the main characteristic peaks of H. procumbens phytosomes are 
present in the combination spectrum, which reflects it does not significantly compromise the 
chemical composition and structural integrity of the H. procumbens phytosomes. This 
suggests chemical compatibility of the phytosomes with the alginate polymer.  
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4.9.6 Swelling index  
The swelling study of the prepared alginate beads was performed in both SGF pH 1.2 and SIF 
pH 7.5. The swelling ratio of alginate beads was 18.96 ± 5.85 % in SGF and 92.45814 ± 0.80 
% in SIF (figure 4.36). 
 
Figure 4-36 : Swelling Index of alginate coated H. procumbens phytosomes in 
simulated  gastric fluid (SGF) and simulated intestinal fluid (SIF). 
 
At pH 1.2 (SGF), the low swelling degree of the alginate coated H. procumbens phytosomes 
could be due to the reduced chemical potential of the network resulted from protonation of 
the carboxyl group (Sathali et al.,2012).  
At pH 7.4 (SIF), the swelling degree of the alginate coated H. procumbens phytosomes was 
high and found to be statistically significant (p ˂ 0.05).  After the alginate coated H. 
procumbens phytosomes swelled, there was structural breakdown. This result is in agreement 
with Sankalia et al, (2005) and Tous et al. (2014) reported alginate beads did not undergo 
swelling in the acidic environment, whereas they swell and disintegrate in intestinal fluid. 
The swelling mechanism at pH 7.4 could be explained by the exchange of ions between the 
calcium ion of alginate beads and the sodium ions present in SIF, under influence of calcium-
sequestrant phosphate ions (Nayak et al., 2011) This ultimately results in a loose structure 
and hence the beads take up more water until bursting of the beads take place and start to 
disintegrate (Pasparakis et al., 2006).  
The result obtained for the swelling test is of importance to our study as it demonstrates 
negligible swelling in the SGF maintaining phytosomes integrity in gastric environment that 
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could affect and deform the phytosomes that entrap and protect the H. procumbens plant 
extract. Further, swelling takes place in the intestinal environment which increases 
phytosome release from alginate matrix which could phytosomal intestinal absorption. 
 
4.9.7 Release study in GIT fluids 
Release study of harpagoside from phytosome-alginate beads was performed in SGF and SIF 
environments. The release profiles are shown in figure 4.37. 
 
 
Figure 4-37 : Release profile of H. procumbens phytosomes in simulated gastric fluid 
(SGF)  and simulated intestinal fluid (SIF).  
 
The drug release from the alginate beads is dependent on the penetration of the dissolution 
medium into the beads, swelling and dissolution of the alginate matrix, followed by the 
dissolution of the drug subsequent to leaching through the swollen matrix (Mandal et al., 
2010; Patel et al., 2016). 
In case of SGF, the alginate beads demonstrated no release at 4 hours and there was no sign 
of bead disruption and it maintained shape even after 4 hours as depicted in figure 4.38. The 
absence of the release the compounds from alginate beads could be related the low swelling 
ability (Shi et al., 2006). Similar finding was reported by Tous et al, (2014) who indicated 
that beads kept their intact form for up to 4 h in acidic pH; with no change in sphericity  and 
low % release (4 %) of sodium diclofenac from sodium diclofenac loaded sodium alginate 
beads was observed in simulated gastric fluid (Saha et al.,2013).  
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Figure 4-38 : intact alginate coated H. procumbens phytosomes in SGF and 
eroded alginate coated  H. procumbens phytosomes in SIF. 
 
In contrast to SGF, H. procumbens phytosomes beads demonstrated a release of 54.05 ± 1.28 
% at 4 hours and 75.55 ± 5.22 % in SIF at 8 hours. This value is the release of the H. 
procumbens from the alginate bead as well as the phytosome as it has to be released from the 
phytosome in order to be detected.  
The lack of release in simulated gastric medium indicates that sodium alginate– H. 
procumbens phytosomes complex is capable of preventing release of phytosomes in the 
physiological environment of the stomach. In addition, the beads release the phytosomes in 
the intestinal environment making it available for intestinal absorption. 
 
4.9.8 Release profile determination 
Coated and un coated H. procumbens phytosomes formulations were subjected to release 
study and compared with the conventional plant extract release. The role of the carrier is of 
particular importance since it must efficiently release the drug and facilitate drug transport 
across the intestinal wall. The release profile for coated and un coated H. procumbens 
phytosomes and freeze dried plant extract were constructed and are shown in figure 4.39.  
 
http://etd.uwc.ac.za/
 
 
116 
T im e  ( h o u r )
%
 o
f
 H
a
r
p
a
g
o
s
id
e
 r
e
le
a
s
e
d
0 2 4 6 8 1 0
0
5 0
1 0 0
1 5 0
H .p r o c u m b e n s
H . p r o c u m b e n s  p h y to s o m e s
A lg in a t e  c o a t e d H .
p r o c u m b e n s  p h y t o s o m e s
 
Figure 4-39 : In vitro release profile of coated and un coated H. procumbens phytosomes and 
freeze  dried plant extract in phosphate buffer solution (pH 7.4, n=3).  
 
During the release process, two distinct release phases were noticed for the phytosomes. The 
first was characterized by rapid release (pulsatile release) during the first 1 hour, which could 
be related to release of drug adsorbed on the surface of the phytosomes; in the second phase, 
the release rate slowed down, demonstrating controlled drug-release behaviour as shown 
in the figure.  From graph shape it is noted that prepared alginate coated and uncoated H. 
procumbens phytosomes exhibited a steady drug release pattern over a period of 8 hours. The 
harpagoside release from the two formulations was delayed compared to the conventional 
freeze dried plant extract .Previous studies  reported high percentage release over time from 
phytosomes  ranging between 68 % to 96 % (Singh et al., 2013; Singh et al., 2012; Hou et 
al., 2012;  Santra et al., 2010). This variation in percentage drug release is attributed to many 
factors including the composition of vesicles. 
 
4.9.9 Mechanism of release 
To determine the mechanism of drug release from the alginate beads, the data was treated 
with various models namely, zero-order, first-order, Higuchi, and Korsmeyer-Peppas by 
using the DDsolver software. The models which best fit; the drug releases from different 
formulations are shown in (Table 4.16). 
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Table 4.16: Regression coefficient (R
2
) and release exponent (n) values of different 
H.procumbens formulations 
                                                                     R 
2  
Values Release 
exponent, 
           n Values 
        F                           
Model                 
Zero 
Order 
First 
Order Higuchi 
Korsmeyer-
Peppas 
H. procumbens Plant 
extract -0.277 0.991 0.590 0.997 0.105 
H. procumbens phytosomes 0.655 0.925 0.978 0.997 0.400 
Alginate coated H. 
procumbens phytosomes 0.942 0.985 0.924 0.968 0.752 
 
The best fit model was selected as the one with the highest values of regression coefficient 
(R
2
). The best fit can be observed when looking at the actual versus predicted plots of the 
various models in figure 4.40.1. From the linear regression model, the Korsmeyer-Peppas 
model (R
2 
0.9971) was the best fit model for the H. procumbens phytosomes. 
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(C)                                                                       (D) 
    
Figure 4-40 1- : Release kinetics of phytosomes: (A) zero order plot, (B) first order plot, (C) Higuchi 
matrix  plot, and (D) Korsmeyer Peppas plot.‎ 
 
Drug release mechanism can be determined according to n value. Table 4.17 shows release 
exponent and the equivalent release mechanism from spherical featured delivery systems 
(Zuo et al., 2014). 
Table 4-17: Exponent 𝑛 of the power law and drug release mechanism from phytosome 
delivery systems. 
Sphere Drug release mechanism 
0.43 Fickian diffusion 
0.43˂ n ˂0.85 Anomalous transport 
0.85 Case II transport 
 
The n value obtained for phytosomes indicate that the harpagoside transport out of the 
phytosomes was driven mainly by a Fickian diffusion release mechanism.  
The release kinetics plots for alginate coated H. procumbens phytosomes are illustrated in 
figure 4.40.2. The linear regression analysis, indicates a first order model for alginate beads 
with R
2 
higher than 0.9857. The obtained n value of the alginate beads was 0.75 which is 
within the specified range of 0.43 and 0.85. This indicates the release from the alginate beads 
was predominantly by both diffusion controlled drug release and anomalous transport 
(swelling controlled drug release). 
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                                 (A)                                                                        (B) 
 
 
 
 
 
 
 
 
 
 
     (C)                                                                       (D) 
 
 
 
 
 
 
 
 
  
 
Figure 4-40-2: Release kinetics of alginate beads: (A) zero order plot, (B) first order plot, (C) 
Higuchi  matrix plot and (D) Korsmeyer Peppas plot.‎ 
 
 
 
4.9.10 Storage stability study 
 
1) Physical characteristics 
The storage stability of the H. procumbens phytosomes results are presented in figure 4.41 
 
 
 
0
10
20
30
40
50
60
70
80
0 5 10
F
ra
c
ti
o
n
 d
is
s
o
lv
e
d
 (
%
) 
Time (h) 
No.1 
Observed
Predicted
0
10
20
30
40
50
60
70
80
90
0 5 10
F
ra
c
ti
o
n
 d
is
s
o
lv
e
d
 (
%
) 
Time (h) 
No.1 
Observed
Predicted
0
10
20
30
40
50
60
70
80
0 2 4 6 8 10
F
ra
c
ti
o
n
 d
is
s
o
lv
e
d
 (
%
) 
Time (h) 
No.1 
Observed
Predicted
0
10
20
30
40
50
60
70
80
90
0 2 4 6 8 10
F
ra
c
ti
o
n
 d
is
s
o
lv
e
d
 (
%
) 
Time (h) 
No.1 
Observed
Predicted
http://etd.uwc.ac.za/
 
 
120 
 
 
 
Figure 4-41 : Physical stability of optimized H. procumbens phytosomes formulation at 
3 different  temperatures, (A, B, C) are measurements for particle size, polydispersity 
index and zeta potential  respectively of optimized phytosomes formulation. Data shows 
as mean± sd, n=3, (****= P< 0.0001). 
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At 4-8 
o
C small variation in size was observed for the H. procumbens phytosomes over the 
tested period with a smallest size at 0 day and the largest size at 30 days (p ˃ 0.05) with sizes 
of 527.3 ± 19.7 – 558.7 ± 46.5 nm respectively. The  zeta potential values (-35.4 ± 5.26 to -
38.16 ± 2.51 mV)  of the phytosome remained relatively stable when exposed at a 
temperature 4-8 
o
C, This implies that the prepared phytosomal formulation retained their 
initial charge and thus tendency for aggregation and flocculation was reduced, indicating that 
the prepared phytosomal formulation was more stable under refrigeration.  
At 25 
o
C, there was a statistically significant (p ˂ 0.05) increase in particle size at the end of 
30 days, it changed from 527.3 ± 19.7 to 695.06 ± 11.32 nm. No significant change was 
observed for PDI (0.17 ± 0.001– 0.24 ± 0.065) and zeta potential (-35.4 ± 5.26 – - 40.9 ± 2.70 
mV).   
At 37 
o
C all batches displayed a statistically significant (p ˂ 0.05) decrease in particle size 
(527.3 ± 19.7 – 375.5 ± 22.12), zeta potential (-35.4 ± 5.26 – -25 ± 1.93) and increase in PDI 
(0.17 ± 0.001 – 0.64 ± 0.23). The size reduction and PDI increase is most likely an indication 
of phytosomal breakdown.  
The preferred storage conditions would be 4-8 
o
C as an increase in storage temperature 
contributed to instability of the H. procumbens phytosomal suspension.  
Alginate coated H. procumbens phytosomes were also subjected to storage stability for 30 
days at different temperatures and were tested for particle size changes. Results demonstrated 
that alginate coated H. procumbens phytosomes exhibited consistent size at all three 
temperatures for the 30 days period; this indicates that the alginate coated phytosomes are not 
stable to some extent and are not affected by temperature.  The formulation only exhibited not 
appreciated significant increase in particle size at the end of 30 days at 37 
o
C.  
 
2)  Leakage 
Leakage is a crucial characteristic for the evaluation of drug delivery systems. H. procumbens 
phytosomes and alginate coated H. procumbens loaded phytosomes formulations were tested 
for harpagoside leakage over a 30 day period at 4 – 8 °C, 25 °C and 37 °C. Results are shown 
in figure 4.41.  
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Figure 4-42: Leakage from H. procumbens phytosomes at various temperatures 
over time. 
 
At lower temperature conditions, i.e. 4-8 °C, the phytosomes show fairly high retention of 
harpagoside inside the phytosomes over 30 days with only 5.85 % leakage. When cholesterol 
is incorporated into phospholipid bilayers, hydroxyl polar group of cholesterol is placed next 
to the PC carbonyl groups by formation of hydrogen bonds. Bonding between cholesterol and 
PC can enhance electrostatic repulsion between the phospholipid bilayer and increase its 
stability by limiting the movement of acyl chains of PC (Rasaie et al., 2014; Briuglia et al., 
2015).   
On the other hand, more leakage occurred with increasing storage period and temperature. 
Leaking of 18.85 % and 70.25 % were measured for samples stored at 25 °C and 37 °C 
respectively, at 30 days. The leakage of harpagoside from the phytosomes during storage at 
elevated temperature may be due to the effect of high temperature resulting in transition to a 
liquid of the lipid bilayers together with possible chemical degradation (oxidation and 
hydrolysis) of the phospholipid in the bilayers, leading to defects in membrane packing 
causing vesicle leakage during storage (Shazly, 2012; Agarwal et al., 2002).  
According to the ICH guidelines, a maximum limit of the loss of the active or marker 
constituents at 5–10 % is acceptable (Karioti et al., 2011). Our study suggests the storage 
between 4 - 8 °C of the phytosomal formulation to prevent leakage from the phytosomes, as 
similarly reported by (Bhatia et al., 2004; Trivedi et al., 2017; Sudhakar, 2014). 
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As for alginate coated H. procumbens phytosomes, the alginate beads exhibited stability 
under all conditions as represented in figure 4.42; however, a low quantity of leaking (less 
than 6 %) was noted at the end of 30 days at high temperature (37 °C).  
 
 
Figure 4-43: Alginate coated H. procumbens phytosomes percentage leaking versus 
storage period. 
 
 
Overall, the coating of H. procumbens phytosomes with alginate polymer could reinforce the 
phytosomes stability at room and higher temperatures and decrease or limit the loss of the 
active constituents from the carrier (phytosomes). Moreover, maintain its integrity and show 
maximum protection against the harmful acidic environment that causes phytosomes 
deformation and active constituents decomposition. 
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Chapter 5                       
Conclusion and Recommendations 
 
 
To recap: 
The aim of the study was to develop an optimized liposomal/phytosomal carrier system 
consisting of Harpagophytum procumbens coated with alginate for protection from gastric 
medium digestion.  
 To achieve the aim, the following objectives were set: 
 Development and validation of a rapid, simple and reliable UHPLC method for 
identification and quantification of harpagoside in Harpagophytum procumbens crude 
plant extract. 
 Preparation of liposomes and phytosomes formulations containing Harpagophytum 
procumbens plant extract.  
 Optimization studies of liposomes and phytosomes formulation parameters using 
response surface methodology (RSM). 
 Physio-chemical characterization of prepared liposomes and phytosomes.  
 Formulation and development of an alginate coating method for phytosomal 
formulation encapsulation. 
 To perform in vitro stability of the optimized nano lipid vesicles and alginate coated 
beads in simulated gastric and intestinal medium.  
 Determine the mechanism of release of harpagoside from phytosomes and alginate 
coated phytosomes. 
 Determine the stability of harpagoside in phytosomes and alginate coated phytosomes 
at various temperatures over time. 
 
A simple, accurate, linear, precise and robust UHPLC method for the determination of 
harpagoside in aqueous plant extract was successfully applied. Harpagophytum procumbens 
extract was complexed with phosphatidylcholine (PC) to form liposomes and phytosomes.  
RSM was successfully used as a mathematical tool to provide a prediction model for the 
response to various inputs factors. The predicted RSM values and experimental values were 
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closely matched. The optimum preparation conditions were PC 80 %, cholesterol 5 % and the 
lipid vesicle being a phytosomes.  It was observed that PC and cholesterol affect the 
entrapment efficiency and lipid vesicles size. PC and cholesterol increased the entrapment 
efficiency, although, PC had a more positive effect on encapsulation efficacy than 
cholesterol. High cholesterol content generally decreased percentage encapsulation. The 
particle size of lipid vesicles enhanced as phosphatidylcholine and cholesterol content 
increases. 
The addition of stearic acid to the optimized phytosomal formulation increased the stability 
by improving zeta potential to a suitable value of 30.6 ± 0.80 mV. 
The ionotropic gelation technique was successfully used for preparation of Harpagophytum 
procumbens phytosomes beads using sodium alginate and calcium chloride as a cross linking 
solution. Parameters such as polymer concentration and calcium chloride concentration 
played a noticeable role in achieving high entrapment efficiency, particle size and swelling 
behaviour. In addition, the particle size, zeta potential and leakage rate were the important 
indicators to evaluate phytosomes stability. The phytosomes showed instability in simulated 
gastric SGF (pH 1.2), demonstrated by the increase in the particle size, PDI and a reduction 
in zeta potential after 4 hours of incubation.  
The present study has shown that alginate coated Harpagophytum procumbens phytosomes 
could be used to protect phytosomes from the gastric environment. They are suitable as a 
possible gastro retentive dosage form, as they have a rigid structure that resist biodegradation 
in gastric pH (simulated gastric fluid) but exhibit complete biodegradation in phosphate 
buffer pH 7.4 (simulated intestinal fluid) which could lead to increased availability of intact 
phytosomes for small intestine absorption. 
It is recommended that intestinal absorption studies employing phospholipid vesicle-based 
permeation assays (PVPA) be used to determine uptake of Harpagophytum procumbens 
loaded phytosomes and in vivo bio-distribution of these loaded phytosomes. It would thus be 
of interest to continue developing selected formulations as well as introduce new elements 
into the formulations to achieve more desirable incorporation and retention of plant extract in 
phytosomes and Harpagophytum procumbens in alginate beads. It is also recommended that 
stearic acid be included as an input factor in the RSM software to further optimize the 
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formulation. In addition, this model including the RSM component could be used as a 
precursor to test other medicinal plants for increased intestinal phytosomal delivery. 
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